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This report details the activities and inhibition of metal-substituted human
carbonic anhydrase II (M-HCA-II). The traditional activities (hydrolysis of CO2 and
para-nitrophenol acetate) in addition to new activities (oxidation of 2-aminophenol,
disproportionation of H2O2, and disproportionation of superoxide) were investigated.
Values reported for the relative hydrolytic activities of M-HCA-IIs are reported here for
the first time, ranging from 47.5 % (plus or minus 0.6) to 86 % (plus or minus 4) for the
hydrolysis of CO2 and from 0.299 % (plus or minus 0.012) to 4.72 % (plus or minus
0.015) for the hydrolysis of para-nitrophenol acetate. With respect to new activities, only
the oxidation of 2-aminophenol was observed. Turnover was observed for Fe-HCA-II
(kcat/KM = 3.6 plus or minus 1.3 mM-1 s-1) and Cu-HCA-II (kcat/KM = 8 plus or minus 2
mM-1 s-1).
Inhibition of Zn-, (di-substituted) Cu2-, and Cu/Zn-HCA-II hydrolysis of CO2 and
para-nitrophenol acetate by sulfanilamide, coumarin, and ortho-coumaric acid were
investigated. Sulfanilamide was shown to inhibit: Zn-HCA-II, Cu2-HCA-II, and Cu/ZnHCA-II - (with CO2) KM = 8.9 plus or minus 1.1 microM, 11 plus or minus 2 microM,

8.8 plus or minus 1.4 microM and (with p-nitrophenyl acetate) KM = 8.4 plus or minus
1.0 microM, (none), 8.4 plus or minus 1.4 microM, respectively. No inhibition was
observed for coumarin or ortho-coumaric acid or its derivatives for any CAs studied.
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ABBREVIATIONS
1. CA refers to carbonic anhydrase generally without distinction to isoform or
metal.
2. HCA-II and HCA-I
refer to specific isoforms of human carbonic
anhydrase. HCA-II is the most active, and HCA-I is the most abundant
isoform.
3. BCA and BCA-II refers to the bovine carbonic anhydrase II isoform unless
otherwise specified.
4. X-CA
(X is any metal’s chemical symbol.) refers to CA with a single
metal atom cofactor (i.e. Zn-CA is zinc-containing CA, and Co-CA is cobaltsubstituted CA.)
5. apo-CA

refers to CA in which no metal is present.

6. M-CA and Mx-CA refers to metal-substituted CA (generally HCA-II) with
either a divalent metal or a metal with an unknown oxidation state,
respectively.
7. CuA-CA and CuB-CA
refer to the high affinity (site A) and low affinity
(site B) copper-binding site within HCA-II, respectively.
8. Cu1-CA, Cu2-CA, and Cux-CA refer to CA with a single, bound copper
atom; CA with two, bound copper atoms; and CA with an ambiguous number
of bound copper atoms, respectively.
9. Cu/Zn-CA refers to HCA-II in which copper is bound in site A and zinc is
bound in site B.
10. XO, HRP, and SOD
refer to xanthine oxidase, horseradish peroxidase,
and superoxide dismutase, respectively.
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INTRODUCTION

Carbonic anhydrase catalyzes both the hydration of CO2 and the dehydration of
bicarbonate under physiological conditions (Reaction 1.1). Although additional
substrates for carbonic anhydrase have been identified (Reaction 1.2), this reversible
hydrolysis of CO2 is considered to be its primary function due to the number of different
various physiologies controlled by this reaction and the incredible rate at which carbonic
anhydrase (CA; See page xii for definitions of the highly precise abbreviations used
here.) can catalyze the reaction: kcat = 1.4 x 106 s-1 for human carbonic anhydrase II.1
Enzymologists consider CA to be one of the fastest enzymes known.2 Indeed, even
before its isolation in 1933, enzymologists had been intrigued by its speed.3
CO2 + 2H2 O ⇌ HCO-3 + H3 O+

Reaction 1.1

Reaction 1.2
The significance of understanding the behavior of CA cannot be overestimated.
There is a vast breadth of physiologically important reactions involving CA; including
bone growth, body pH regulation, and cancer proliferation.1,4,5 As an enzyme with a
1

relatively simple, stable structure, CA has a role to play in the movement toward
ecologically responsible, industrial chemistries, as well, and as the fastest known catalyst
for the sequestration of CO2 it would be foolish to rule out a role for it in addressing
climate change.6
1.1

Medical relevance
It might appear with nearly a century of study on carbonic anhydrase that its

relevance with respect to continued study is quickly dissipating, but it is not. In fact,
John T. Edsall has described the trend in the history of the popular study of CA as ebbing
and flowing greatly over decades with each flow of interest focused by a different aspect
of the nature of CA.7 Three areas of study in particular have spurred the most recent
interest in carbonic anhydrase: medical research, new bioinorganic catalysis, and catalyst
modeling via metal-substitution. Carbonic anhydrase is an important enzyme involved in
a variety of essential physiological processes, which are now being studied through the
vantage point of diseases like cancer. Interest in discovering new chemistries available to
CA is growing.8-10 In addition, the intrinsic properties of carbonic anhydrase have given
rise to its use as a model protein for studying other inorganic and biocatalysts via metalsubstitution. With respect to medical research, bicarbonate in humans is involved in
diverse processes throughout the body: (i) as a counter ion in sodium and chloride
transport,11-13 (ii) as a carrier for CO2,14 (iii) as a buffer,11,15,16 (iv) as a metabolite in
biosynthetic reaction pathways,17 (v) in regulation of respiration and gas exchange, (vi)
vision,15,18-20 (vii) development, function, and pathology of bone,18,19 (viii)
metabolism,1,17 (ix) signaling and memory,1,11,13,19 (x) gestation,1,21 (xi) production and
regulation of secretory fluids – salivary, seminal, pancreatic, cerebrospinal, and aqueous
2

humor,13,15,19 (xii) intestinal transport of ions,12 (xiii) muscle and nerve function,12,13,17
(xiv) “rendering of spermatozoa quiescent”,11 (xv) adaptation to cellular stress –
oxidative stress [S-thiolation/dethiolation],17,22 (xvi) acidification of the extracellular
environment around hypoxic tumor cells,23 (xii) gastric acid production,19 and (xiii)
several biosynthetic pathways – tricarboxylic acid cycle, glucogenesis, and
ureagenesis.18,19,24
In the eye, CA-II is present in the lens, vitreous body, cornea, retina, and ciliary
body. In the ciliary body, CA-II manages the transport of sodium into the eye, which is
accompanied by the transport of water. As the primary mechanism for the transport of
sodium and water into the aqueous humor, CA-II is very important in determining the
shape of the lens via intraocular pressure. Too much pressure in the aqueous humor is a
symptom of glaucoma, and the inhibition of CA-II with arylsulfonamide drugs is used as
a treatment. Inhibitors of CA-II are also used to treat macular degeneration and macular
edema.1,18,20
With respect to bone development regulation, bicarbonate is necessary for the
acidification around osteoclasts required for bone resorption at the osteoclast-bone
interface. A rare genetic disease, osteopetrosis, which results from CA-II deficiency,
manifests as a failure of bone remodeling. This causes bones to be much too dense and
brittle. The inhibition of CA-II is used as a treatment for the much more common
osteoporosis.1,18,19
Two other isozymes have also been linked to vital biochemical processes in the
body: HCA-V and HCA-IX. In the mitochondria, HCA-V is required for
gluconeogenesis by providing bicarbonate for pyruvate carboxylase. Pyruvate
3

carboxylase is an enzyme that is vital for the synthesis of fatty acids, amino acids,
neurotransmitters, and porphyrins.17,25,26 HCA-IX has been implicated in the growth of
several types of tumors. HCA-IX is over-expressed in tumor cells, and its role is
currently being deduced. Some of the reactions involving HCA-IX are “the hypoxiainduced acidification of the extracellular environment of hypoxic tumor cells.”1 This
acidification increases the invasive behavior of these cells, so an inhibitor specific to the
CA-IX isomer is being sought for the treatment of cancer.1,23
1.2

Historical perspective on the development of carbonic anhydrase research
In the decades leading up to the discovery and isolation of carbonic anhydrase,

physiologists became increasingly interested in the pathways through which carbon
dioxide exchanges in the blood. Roughton details (in his early yet seminal review over
this chemistry) that his own work in 1925 and that of Henriques in 1928 described that
the rate of CO2 conversion to HCO3- within the capillaries occurred at a rate much greater
(less than one second) than that allowed by simple equilibrium (approximately fifteen
minutes.)3 By the early 1930s biochemists suspected that the conversion was catalyzed
by an enzyme. Two groups isolated the enzyme, and in 1932 Roughton and his student,
Meldrum, were the first to publish an account of the isolation of the enzyme from red
blood cells in various species.27,28 They named it carbonic anhydrase. Later, Roughton
detailed the tests he used to verify that an enzyme is responsible for CO2 conversion in
the blood.29 These tests take advantage of properties which were believed to be almost
universal to enzymes at the time: denaturing with extended heating, manipulating the
turnover by varying the amount of protein present, inhibiting the activity with known
enzyme poisons – including Cu2+, etc. Stadie and O’Brien followed up with their
4

detailed account a few months later.28 Though this early research with the impure CA
was crude, it laid the foundation for much of our understanding of CA today. Indeed,
Roughton’s observations were so steadfastly adopted by the CA community that either
they were held many decades after it became obvious that they should have been
reevaluated or they still stand today with very little reevaluation.
Because the original work I am presenting here represents a fundamental change
in the eighty-three-year-old doctrine describing the behavior of M2+-bound CA
(especially Cu2+-CA), I feel I need to give the reader an idea of the slow evolution in the
understanding of the properties of carbonic anhydrase. Some important milestones in this
development and the length of time it took to arrive there from the naming of CA in 1932
are listed.27 In 1940 (eight years after CA was isolated),29 Keilin and Mann determined
that zinc was not a mere impurity in CA,30 but the exact roll of zinc remained in question
even after Davis’ seminal paper on CA in 1959 (after twenty-seven years).31 Edsall, a
giant in the study of CA, was still referring to the inhibition of CA activity by excess Zn
thirty-five years after the initial isolation of CA.32 In 1960 (after twenty-eight years),
Lindskog published the first widely adopted purification of CA and the first description
of two major bovine isozymes of CA.33 (One of his three, original isozymes is no longer
considered an isozyme.)34 His description of the isozymes only became widely accepted
twenty-four years after his publication.35 In fact, the nomenclature of those isozymes was
disputed, changed, and finally standardized twenty-four years after their isolation, which
was fifty-four years after CA was first isolated. See Table 1.1 for a description of the
current nomenclature. The currently accepted forward and reverse rates of hydration and
dehydration of the CA substrate (Table 1.2) were not definitively published until thirty5

nine years after Roughton’s first publication on CA,36 and our work will add to this long
investigation into the nature of CA, eighty-three years on, with evidence that Cu2+ is not
an inhibitor of HCA-II (Human Carbonic Anhydrase – isozyme II) activity as described
by Roughton in 193329 and many others since.18,33,37-61
Table 1.1

Human carbonic anhydrase nomenclature

Isozymes
Nyman62
Laurent63
(Fraction/Activity/Abundance)
1 / low / least
II
X2
2 / low / highest
III
X1
3 / high / moderate
V
Y
*This fraction was determined to be a derivative of HCA-I.
Table 1.2
Isozyme
HCA-I
HCA-II
HCA-III
HCA-IV

A
B
C

Currently
Accepted18,34
N/A*
I
II

kcat (s-1)
9.5 x105
3.4 x105
3.8 x105
4 x105

kcat/KM (M-1s-1)
9.8 x107
4.9 x107
5.5 x107
7.4 x107

Rickli64

Rate constants for the hydrolysis of CO2 1
kcat (s-1)
2 x105
14 x105
0.1 x105
11 x105

kcat/KM (M-1s-1)
5 x107
15 x107
0.03 x107
5 x107

Isozyme
HCA-VB
HCA-VI
HCA-IX
HCA-XII

According to S. Lindskog et al., carbonic anhydrase is such a tremendously
efficient catalyst for the reversible hydrolysis of carbon dioxide that it has a “maximum
turnover numbers among the highest known for any enzyme.”2 Carbonic anhydrase has
also been found to catalyze the hydrolysis of certain esters (Reaction 1.2), aldehydes, 2,4dinitro-fluorobenzene, and sulphonyl chloride; yet, due to the much greater degree with
which this enzyme hydrolyzes CO2, its physiological functions have been ascribed to the
hydrolysis of CO2.1 Though carbonic anhydrases overwhelmingly efficiently catalyze the
hydrolysis of CO2, Lindskog’s isozymes are not equal in their activity (Table 1.2).

6

1.3
1.3.1

Classification of carbonic anhydrase
Families and important isomers of carbonic anhydrase
The list of isozymes of carbonic anhydrase has grown so long that they are

divided into five families depending on the evolutionary origin of the isozyme: αcarbonic anhydrases - from animals (all mammalian CAs), plants, eubacteria, and viruses;
β-CA – plants, bacteria, and animals; γ-CA – bacteria and plants; δ-CA – a single marine
diatom (Thalassiosira weissflogii); and ε-CA – bacteria.1 CA from fungi have only
recently been identified, and it is believed that they will belong within the α-CA and βCA families.65 Nevertheless, our work focuses on human carbonic anhydrase (HCA),
within the α-CA family. According to the most recent and extensive CA review to date
by Vijay Krishnamurthy, et al.,1 there are nine isozymes identified as HCAs. There are
more than six other isozymes found within the other CA families. The greatest interest
has always been on two human isozymes and one bovine carbonic anhydrase (BCA-II).
Traditionally, the human carbonic anhydrase of most interest have been HCA-I (Human
Carbonic Anhydrase – isozyme I), dominating the literature until the mid-nineties. HCAII now overwhelmingly dominates, and it is the subject of this study.
Along with their isozyme names, CAs are also referred to simply by their
predominant hydrolytic activity: HCA-I has moderate to low activity (kcat = 2 x 105 s-1)
and HCA-II has quite a high activity (kcat = 1.4 x 106 s-1).1 These two isozymes also
differ with respect to abundance. The CA-I isoform is in the highest concentration in
human red blood cells, and CA-II is the best represented across all species studied.58
With respect to these non-human species, CA-II is so globally ubiquitous that the isoform
has been found in all studied species. Within all these species, CA-II is involved in the
7

regulation of biochemical pathways as diverse as bone growth and regeneration1,18,19 and
the fluid pressure of the aqueous humor in the eye, as detailed in section 1.1 of this
work.1,15,18-20 CA-II is seen as the first evolved isoform because CA-II is present in all
studied species with little or no variability in structure or catalytic rate. In contrast, CA-I
has multiple variations among different mammalian and non-mammalian species.18,66
Even though, the structures of HCA-I, -II, and BCA-II may be very different,45,49,52 their
fundamental structure is similar:1 they are all approximately 30 kDa in size; they all
contain one zinc ion in the active site per protein molecule; and the zinc in each active
site is coordinated to three histidyl side-chain residues and a water molecule. Bovine
CA-II (BCA-II) is the dominant isoform studied because it has similar activity to HCA-II
and it is much more abundant and inexpensive than HCA-II.54
1.3.2

Homology and Function
The isoforms of carbonic anhydrase show a great deal of secondary and tertiary

structural homology as globular proteins. According to Krishnamurthy, et al., the
globular shape of the protein is a prolate ellipsoid with a diameter of 40 and 42 Å (minor
axes) and 56 Å (major axis).1 As seen in Figure 1.1, the structure of the animal class of
carbonic anhydrases (α-CA) is dominated by a central, ten-stranded, twisted β-sheet with
several α-helices surrounding the sheet. An aspect of CA structure which is rare in
proteins is the presence of the C-terminal knot, labeled in Figure 1.1. Alam has shown
that if this knot, which is far from the active site, is disrupted, CA activity is destroyed.67
The globular structure of CA-II can change in solutions of varied pH, upon ligandbinding, and, to a lesser extent, upon removal of the zinc cofactor.1 These changes can
all lead to varying degrees of lowered activity.
8

Figure 1.1

Features of human carbonic anhydrase II

C-terminal knot, N-terminus, zinc co-factor, active site residues, and His64. (PDB:
2CBA at 2.54 Å resolution.)
The active site of carbonic anhydrase is a complex structure, which is shared by
its isoforms. As can be seen in Figure 1.2, the active site is basic and hydrophobic in
nature. Yet there are large, polar regions in the protein. These polar areas are thought to
chauffeur the bicarbonate out of the active site. There are three functional regions
comprising the active site: (i) the zinc ion, three histidyl residues (i.e. His94, His96, and
His119) which bind the zinc, and a water molecule (or hydroxide ion) which is bound to
the zinc; (ii) two hydrophobic faces for the binding of ligands and substrates; (iii) a
9

hydrophilic face believed to facilitate the regeneration of the catalytic center. In all
isoforms the active site sits at the bottom of a conical cavity (15 Å in diameter and 15 Å
deep). At the vertex of the cone lies the zinc ion.1

Figure 1.2

Surfaces of human carbonic anhydrase II

These surface projections illustrate polarity (A and B) and acidity (C and D) of the surface residues of
HCA-II from two orientations (Front: A and C; Side: B and D) For A and B, black and white represent
hydrophobic and hydrophilic residues near the surface, respectively. The yellow and green colors represent
the positions of the basic (during protonation) and acidic (during deprotonation) His64 residue,
respectively. The dark gray color pointed out in A and C represents the position of the Zn co-factor near
the surface. The blue color in A represents the His94, His96, and His119 residues. For C and D, blue
represents acidic residues near the surface, red represents basic residues near the surface, and white
represents neutral residues near the surface. In B and D, the arrows point out the location of the active site
in those images.
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The residues of the hydrophobic face make up a primary and secondary binding
site. These sites are located above and to the right of the active site, with respect to the
orientation in the figure. The primary hydrophobic site is referred to as the hydrophobic
pocket. In this pocket Val121, Val143, Leu198, Trp209, and Val207 bind CO2 in the
proper orientation for the zinc-bound hydroxide to hydrolyze the CO2. The secondary
hydrophobic site is not near the zinc cofactor and is known to be involved in binding
inhibitors of carbonic anhydrase.1 We have demonstrated previously,68 as have
others,52,69,70 that there is a higher affinity, second metal-binding site near the N-terminus.
The hydrophilic face of the binding cavity was first characterized in 1988.1 There
are eight residues making up this face: Thr199, Thr200, His64, Tyr7, Asn62, Asn67,
Gln92, and Glu106. Thr199 and His64 are directly involved in the catalysis while the
others indirectly support the reaction (Figure 1.3). Five of the residues, Tyr7, Asn62,
Asn67, Gln92, and Glu106, are involved in a hydrogen-bonding network with water
molecules local to the active site, and three residues (i.e. Try7, Asn62, and Asn67) also
facilitate the proton transfer between the zinc ion and His64. This hydrogen-bonding
network contributes to enzymatic activity, has an effect on the affinity of zinc for the
active site, and facilitates the proper orientation of the imidazole rings of the three
histidine residues which coordinate to the zinc ion.1
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Figure 1.3

Hydrolysis of CO2: mechanism and hydrogen bonding network1

It is important to note that the residues buried around the active site are also
involved in the hydrogen-bonding network. The Glu117 residue is buried away from the
12

active site, but it is hydrogen bonded to the His119 residue through this solvent network.
So, according to Eriksson et al., this allows the two positive charges of the zinc to be
stabilized by three negative charges even at high pH.71 The nine water molecules which
take part in the hydrogen-bonding network in the active site are very important in other
fashions as well. This network, which the water molecules facilitate, is responsible for
orienting the Thr199 in such away as the Oγ11 atom of the Thr199 can hydrogen bond
with the hydroxyl group on the zinc ion. The hydroxyl group is oriented so as to align its
lone pair electrons for a nucleophilic attack on CO2 to produce bicarbonate.
In the catalytic cycle (Figure 1.3), the His64 residue acts as a “proton shuttle” to
aid in the deprotonation and transfer of a proton from the zinc-coordinated water
molecule (universally referred to as water263) to buffer molecules. Understanding the
nature of water263 is important because it leads to an understanding of the catalytic
hydration of CO2 and the binding of inhibitors. For most known Zn2+-metalloenzymes,
the activation of water is the mechanism that allows for catalysis.72 For carbonic
anhydrase, the activated water is deprotonated to hydroxide.1 In fact, it was deduced
from experimental data73 and has been confirmed with computational data74 that a major
function of the zinc cofactor is (i) to lower the pKa of the water molecule by electrostatic
interaction, and (ii) to maintain the nucleophilic character of the hydroxyl group for
attack on CO2. The accepted pathway for the hydrolysis of CO2 is thought to take
multiple steps: (i) nucleophilic attack of CO2 by the zinc-bound hydroxide to form
bicarbonate, (ii) coordination of a water molecule in the active site to the zinc ion
adjacent to the bicarbonate ion, (iii) removal of the bicarbonate through the hydrophilic
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residues opposite the active site, and (iv) deprotonation of the bound water263 (Figure
1.3).75
Because the hydrolysis and esterase activity of carbonic anhydrase is pH
dependent, scientists have suggested that there is a single ionizable group used in both
catalyses, and that group is thought to be water263.43,76 The accepted value of the pKa
for HCA-I, -II, and BCA-II is 6.8.1 Mutations of the residues immediately surrounding
the zinc ion have shown a great dependence of the pKa on those residues described
previously as being involved directly and indirectly in the activity of the active site:
Thr199, Thr200, His64, Tyr7, Asn62, Asn67, Gln92, and Glu106. A mutation of these
residues modulates the pKa, but according to computer simulations the Glu106, Glu117,
and Arg 246 residues have the greatest influence over the pKa.1 The deprotonation of the
bound water263 is the rate-determining step, which further underscores the importance of
the pKa of the CA-Zn2+-OH2 complex. More specifically, Merz, et al. calculated in 1988
that in highly concentrated buffer, within the proper physiological pH range, that the rate
determining step is the “intramolecular proton transfer from [the zinc-bound water
molecule] to [His64],” and in less concentrated buffer (same pH range) that the
“intermolecular [proton transfer] is rate determining.”74 The intermolecular transfer is
from the His64 to local buffer molecules.
1.4
1.4.1

Metal-substituted carbonic anhydrase
Probing the mechanism
Although efforts to substitute different metal ions for Zn2+ in CA only began in

earnest in the 1960s,37 the introduction of metal salts into CA solutions began with the
original investigations of CA activity in 1932.29,30 Initially, the use of various metal salts
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in studying CA had more to do with attempting to understand the physiological
conditions under which CA functions best. This was originally the only reason for
studying metal-CA interactions.28-30 Before 1940, the original purification resulted in a
thirty-three percent Zn-incorporated CA, and CA was not recognized as a metalloprotein.
Zinc was thought to be an impurity because of its poor incorporation and its acting as an
inhibitor when added in excess. Even now, the most complete study of the effect of CA
activity in the presence of different metals was the second paper to describe CA.29 In
1933, Roughton used twenty-two different metals of various oxidation states across the
periodic table (an antiquated version no longer in use) to monitor their effect on the
activity of CA: Na+, K+, Be2+, Mg2+, Ca2+, Cd2+, Al3+, Fe2+, Fe3+, Pt4+, Cu2+, Ag+, Au3+,
Zn2+, Hg2+, Cex, Tix, Pbx, Crx, Mnx, Cox, Nix, VO2+. (In his paper, Roughton fails to
mention the oxidation state of many of the metals, and he appears to mistake “Va” for the
symbol of vanadium, which has never been its symbol. He is probably using that symbol
to represent the vanadyl ion, but he explicitly refers to it as vanadium in the text.) Of
those metals, Cu2+, Ag+, Au3+, Zn2+, and Hg2+ were all identified as “poisons” to CA
activity.29 The inclusion of the zinc ion illustrates that understandable flaws existed in
Roughton’s original method. Five years after the first seminal review of CA30, Keilin and
Mann used metal salts to discover the true nature of CA as the first zinc metalloenzyme.
Over time, the purposes for using metals to study CA diversified, and generally, there are
three reasons for these studies: 1) to study the physiological conditions leading to optimal
CA activity, 2) to model Zn-CA interactions which are otherwise not possible with
spectroscopic techniques, and 3) to investigate new functions for CA.77

15

1.4.2

Metal-coordination spectroscopy
The next group of investigators to study Mx-CAs (CA with a metal cofactor of

ambiguous charge) needed a technique that would allow them to take advantage of
attractive spectroscopic techniques by circumventing the spectroscopically silent nature
of Zn2+. (For the purposes of clarity, the reader should refer to the “ABBREVIATIONS”
section in this work for a complete description of the conventional and newly developed
symbolism used to describe the metal-substituted carbonic anhydrases presented here.)
In 1960, Lindskog published the first reliable and efficient method to prepare stable apoCA (CA without a metal cofactor).37 In solving the problem of reversibly chelating metal
out of Zn-CA, Lindskog provided a method by which he and others could use
spectroscopically active metals to prepare Mx-CAs from which they could extrapolate the
properties of Zn-CA, including metal binding, coordination, and mechanism. The
purpose of the first of these metal-substitution studies was to verify the 1940 study by
Keilin and Mann.37 Lindskog reported that, of the metals used, only Zn restored full
activity to the apo-CA.38 In 1962, he reported various properties of Cux-CA, Co-CA, and
Zn-CA including the molar absorptivities and EPR spectra of Cux-CA and Co-CA.
Throughout the early 1960s, Lindskog, Coleman, and Edsall published research through
which they slowly elucidated the mechanism of CA. Though Edsall seems to have
favored the native enzyme,32,36,78,79 Lindskog,37-39,41,80 Coleman,40,42-44 and others81-83
used M-CAs (CA with any metal cofactor) to probe metal coordination and the structure
of the active site with EPR and vibrational spectroscopy. They also investigated the
native activity CA with these M-CAs to understand the mechanism. Into the 2000s,
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subsequent groups continued the use of M-CAs to study the basic structure, mechanism,
and various properties of CA.46,49,52,53,69,84-87
In addition to the mentioned spectroscopic investigations which were used to
elucidate structural and reactivity properties of M-CAs in solution, x-ray crystallography
has been used since the 1960s to shed light on the static, crystal structure of MCAs.57,81,83,84,88 Of particular interest in this study, the crystal structures of Co-CA, MnCA, Cu2-CA, and Ni-CA solved at a resolution of 1.92 Å have all been reported.70 These
crystal structures are presented (Figures 1.4-1.7) as they were described in the original
report. (Cu2-CA is CA with two bound copper atoms.) It is possible however that in
Figure 1.4, the distal oxygen atom of the oxygen molecule is coordinated to the cobalt,
given their distance of 2.721 Å, which is the case in the Cu2-CA structure (Figure 1.5).
Given the near 120o (O-O-M) angles and O=O bond lengths longer than the accepted
1.21 Å for molecular oxygen (1.257 Å for O=O-Co and 1.277 Å for O=O-Cu), these may
be stable, aqueous, end-on M-superoxo complexes, which would be of great interest.89-92
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Figure 1.4

Co-HCA-II x-ray crystal structure

The coordination is considered to be tetrahedral; however, it is possible that the molecular oxygen is
coordinated at a distance of 2.721 Å. The coordinating ligands are His94 His96, His119, and water. (PDB:
1RZA at 1.92 Å resolution)

Figure 1.5

Cu2-HCA-II x-ray structure with the CuB site shown

The structure is penta-coordinate. The coordinating ligands are His94, His96, His119, water, and O2.
(PDB: 1RZC at 1.92 Å resolution)
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Figure 1.6

Mn-HCA-II x-ray structure

The structure is penta-coordinate. The coordinating ligands are His94, His96, His119, water, and SO42-.
(PDB: 1RZD at 1.92 Å resolution)

Figure 1.7

Ni-HCA-II x-ray structure

The structure is hexa-coordinate. The coordinating ligands are His94, His96, His119, two water molecules,
and SO42-. (PDB: 1RZE at 1.92 Å resolution)
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1.4.3

New devices and substrates
Today, most of the work done with M-CAs is designed to investigate or create

new products or catalyzed reactions.93-96 Fierke has pioneered the use of CA as a sensor
for different metals in solution.93-95 She even reports picomolar detection limits for Cu
with one of her sensors. In addition to adapting CA into a metal sensor, groups led by
Soumillion8 and Kazlauskas9,10 published reports of having converted CA into an epoxide
synthase by merely preparing Mn-CA. The goal of the original work presented here was
initially to extend the list of new substrates available for catalysis by M-CAs before it
became an investigation of two oddities: the native activity of Cu2-CA, which should not
exist according to eighty-three years of literature,29,53,54 and the absence of any inhibition
of CA by coumarin, the inhibitor of the moment in CA-IX medical research, or 2hydroxycinnamic acid.20,23,97-99 As described later, the coumarin chemistry could not be
repeated in Dr. Joseph Emerson’s lab at Mississippi State University in Starkville, MS;
Dr. Seth Cohen’s lab at the University of California in San Diego, CA100; or Dr.
Daumantas Matulis’ lab at Vilnius University in Vilnius, Lithuania.101
1.4.4

Curious case of Cux-CA
Copper-substituted CA has been a part of many of the seminal CA structure

papers since 1932. There are more than twenty-six papers which use Cu to characterize
the active site of CA, probe M-CA interactions, or investigate the inhibitory behavior
which has been attributed to Cux-CA coordination.29,30,33,37-40,42,43,45-55,81,83,84,87 Although
there have been many reports of Cux-CA activity which have been generalized to
describe Cux-HCA-II activity (i.e. CO2 and p-nitrophenyl acetate hydrolysis),3,29,30,33,3740,42-48,52,55,81,83,84

there has been only one report of the activity of Cu2-HCA-II. In 2013
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Song reported the oxidation of 2-aminophenol by the activation of H2O2 by Cu2-HCAII.68 The only other M-HCA-II activity that appears to be reported is the inability of
Mn2+-HCA-II to hydrolyze p-nitrophenyl acetate, which is more fully developed later in
this discussion. Indeed, in eighty-three years of rigorous study no instance of any
concerted effort to investigate the ability of any metal-substituted HCA-II to hydrolyze
carbon dioxide is noted. Culling information about Cux-HCA-II from previous reports is
not a quickly accomplished task due to the sheer number of reports involved and the
number of these which refer to papers that describe only data for isomers and/or M-CAs
other than Cux-HCA-II (i.e. BCA or HCA-I).37-47,54,55,81,83 In addition, there is a long
chain of cross references throughout these papers (which include nearly every paper
published on Cux-CA since 1960) citing papers with no HCA-II data, while the chain
eventually leads back to the same five papers.37-40,43 Some references even cite reports
published prior to both the discovery of CA isomers and the successful purification of
fully metallated Zn-CA.18
Nearly thirty reports over thirty-nine years have discussed this inhibitory behavior
since the discovery of CA isozymes, but twenty of these simply generalized the behavior
of BCA and/or HCA-I to HCA-II.18,33,37-61,102 Lindskog even generalizes the publications
of a few Hg-CA crystals to explain the lack of Cux-CA activity, and another by Hunt
simply foregoes any citation.53,54 To be clear, not all studies – even the original studies –
suggest or present data showing that Cu quenches all activity.30,42,47,49,52,55,57,103 Again,
none of those publications report values for the activity of Cu2-HCA-II. Unfortunately,
after raising interesting questions about the Cux-HCA-II structure and activity, the
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authors do not go on to investigate the odd behavior they describe, which in some cases is
only revisited and/or explained decades later.52,69,104
To date, I know of only six publications describing Cux-HCA-II.48-52,87 Only two
of those reports describe catalysis, and both describe only the inhibition of Zn-HCA-II
catalysis by a CuSO4 solution.48,52 Since it is well known that Cu has a higher CA
binding affinity than Zn and sulfate itself has been implicated as an inhibitor of CA, these
papers indirectly support the central thesis of this dissertation.39,53,87,105,47,54,96,106,107 As
Cu replaces Zn 1:1 within CA, the CA loses activity not because Cu is inhibitory, but
because Cu2-CA and Cu/Zn-CA have a lower activity than Zn-CA, thereby, appearing to
inhibit the activity. (Cu/Zn-CA is CA with a zinc atom bound in the native active site
and a copper atom bound in the high affinity site.)
1.5

Objective of this work
The major focus of this work is to report the investigation of new chemistries with

metal-substituted human carbonic anhydrase II and the use of M-HCA-II to model the
catalysis of other enzymes (i.e. catalase, superoxide dismutase (SOD), and horseradish
peroxidase (HRP).)
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CHAPTER II
PRODUCTION OF METAL-SUBSTITUTED HUMAN CARBONIC ANHYDRASE II

It should be obvious that the production of pure, concentrated, active human
carbonic anhydrase II is the necessary first step in any research program including HCAII. Though it is the first step, it is not at all a simple step. In this work, a HCA-II vector
was used in a E. coli-based protein expression system to produce HCA-II. When the
HCA-II is removed from the microbial cells, it is contaminated with various proteins,
DNA, and other biomolecules. These biomolecules were separated from the HCA-II with
ion-exchange, affinity, and size-exclusion chromatography in addition to a variety of
other techniques to characterize the purity, concentration, and metal content. These
techniques were used in conjunction with a variety of methods used to manipulate these
properties of the protein.
2.1

Molecular and microbiological methods used in the production of the wildtype HCA-II
The traditional method of purifying HCA-II is the extraction of HCA-II from

human blood.29,30,32,36,52,55,108-111 In this method the complete separation of HCA-II from
hemoglobin is incredibly difficult.112 In fact, previous investigators have shown the
complete separation to be impossible even with affinity media designed for HCAII,33,64,113 and this method is now considered by many to be obsolete for HCA-II. The
advent of microbial protein expression systems was a welcome development for
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enzymologists working with HCA-II, and it is the only method shown to provide HCA-II
without hemoglobin contamination. This is important because the intensity of
hemoglobin’s protein absorption spectra (λ280 nm) and heme absorbance bands (λ410 nm)
interfere with UV-Vis absorbance assays commonly used for HCA-II work. This work
uses the E. coli BL21(DE3) and E. coli Rosetta(DE3) expression systems with a plasmid
vector designed by and generously donated to Dr. Emerson’s lab by Carol Fierke.114 The
plasmid, labeled pACA, produces a mutant protein which differs from the native HCA-II
by only two residues at the N-terminus. The N-terminus of the wild-type HCA-II is an
acetylated serine (Ac-Ser) residue, but Met-Ala substitutes for the Ac-Ser terminus in the
mutant. This vector also confers ampicillin resistance to the E. coli host. Finally, the
vector is regulated by the T7 promoter and has an f1 origin of replication. Since pACA
was designed and cloned in another lab, used unchanged in this work, and described in
another publication,114 it will not be described further here.
2.1.1

Maintenance and multiplication of competent cells
The original competent cells used in this study were taken from stocks purchased

from EMD Millipore [E. coli BL21(DE3) and E. coli Rosetta(DE3)]. This stock of
competent cells was maintained, by the common method,115 to provide all of the
competent cells used by Dr. Emerson’s lab.
Until mid-2013, pACA was transformed into the BL21(DE3) expression system,
but this cell line was abandoned because I discovered that pACA contains rare codons,
and the BL21(DE3) cell line does not provide an increased number of necessary rare tRNA to translate these codons. This means that BL21(DE3) is a poor cell line for pACA,
but the E. coli Rosetta(DE3)116 cell line does provide the additional t-RNA needed to
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efficiently translate plasmids containing rare codons. So, E. coli Rosetta(DE3) became
the cell line I used in mid-2013. Changing the cell line created a more efficient
expression of HCA-II. It must be noted that the Rosetta(DE3) cell line requires the
antibiotic chloramphenicol for proper optimization of the culture. Chloramphenicol
resistance is encoded in the plasmid that codes for rare codons in Rosetta(DE3). Without
this antibiotic, the Rosetta(DE3) cells that lose this plasmid may continue to grow,
express pACA inefficiently, and compete with those cells which express the protein more
efficiently, thereby lowering the efficiency of the entire culture. I was unaware of that
until after this research was completed. The transformation of pACA into either cell line
proceeded by the common heat transformation method.115
2.1.2

Maintenance, multiplication, and transformation of the plasmid
Because the pACA stock necessary for transformations is finite, the plasmid had

to be multiplied in preparation for the possibility of multiple transformations. The
plasmid was multiplied and extracted using a QIAprep Spin Miniprep Kit (250)
[QIAGEN].
After the transformation of pACA into the E. coli Rosetta(DE3) cell line, the cells
grown hosting pACA were preserved in glycerol stocks. These stocks indefinitely
preserve the cells containing pACA,115 so cell growths needed for the production of
HCA-II can easily be started with scrapings from these frozen stocks.
2.1.3

Cell cultures, induction, and cracking
An optimized the media is needed to efficiently culture the E. coli Rosetta(DE3)

cell line. While researching the optimized conditions needed to culture E. coli, in
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general, I developed a method that greatly increased the cell mass collected after the
culture process.117-121 The final steps in the production of HCA-II, which are strictly
biological in nature, are the induction of the protein expression, collection of cells by
centrifugation, and liberation of the protein by sonication of the cells collected. In
culturing any of the E. coli cell lines, the common method described in the Current
Protocols of Molecular Biology115 was followed.
2.2
2.2.1

Purification, characterization, and reconstitution of metal-substituted HCA-II
Purification and characterization of wild-type HCA-II
Once the lysate containing wild-type HCA-II was recovered, the purification of

HCA-II was accomplished with two columns: a DEAE weak anion exchange column
[BIO-RAD UNO Q12 Column] and a high resolution, size exclusion column [GE
Healthcare HiPrep Sephacryl S-200 High Resolution Column]. With respect to the weak
anion exchange column, the fraction containing HCA-II was the first fraction to elute in
the low salt buffer at pH 7.4, due to the greater stability of the holo-HCA-II at this pH.
Because the pI of HCA-II is 7.361, running the protein over an anion exchange column at
pH 7.4 was not ideal. Proteins are meant to be run above or below their pI on ionexchange columns. Proteins buffered above their pI are anionic, so proteins run under
this condition are run on anion-exchange columns. Conversely, proteins buffered below
their pI are cationic, and proteins run under this condition are run on cation-exchange
columns. In this way, proteins exchange with ions bound to the chromatographic media
and bind to the column. Using the anion exchange column in the way we have
effectively makes this column into a filter, thereby, allowing an effective way of quickly
separating HCA-II from some proteases and cell debris in the lysate. Generally,
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proteases quickly degrade the HCA-II after cracking the cells, and this also provides an
efficient way of limiting HCA-II degradation. HCA-II was buffered at pH 7.4 because
the majority of assays that we run are buffered near that pH.36,96,122-125 Essentially, we
used the anion exchange column to remove as much contamination as possible and to
stabilize the HCA-II in the absence of proteases. After the protein solution was thinned
by ion exchange, it was concentrated and run over a high-resolution size-exclusion
column. It is this column that provides the purest HCA-II. Figures 2.1-2.3 illustrate the
protein separation and purity accomplished by the high-resolution column.

Figure 2.1

Zn-CA separation with high-resolution size-exclusion chromatography

Protein taken from the anion-exchange column were further purified as seen here with the
HiPrep Sephacryl S-200 High Resolution Column. Fractions 31-37 contain a mixture of
Zn-CA and apo-CA. The different UV-Vis traces represent the absorbance at 214 nm
(light blue), 280 nm (green), 260 nm (purple), and 405 nm (orange). This column was
run under 50 mM Tris/ 250 mM NaCl buffer at pH 7.4.
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Figure 2.2

Apo-CA separation with high-resolution size-exclusion chromatography

Apo-CA (fractions 30-34) is separated from the chelator, DPA, with HiPrep column under the same
conditions as described in Figure 2.1.

Figure 2.3

Zn-CA and apo-CA SDS-PAGE

Protein characterization by gel electrophoresis. Lanes 1-5 contain fractions 32-36 seen in Figure 2.2.
Lanes 6,7, and 9-14 are fractions 17, 25, 31-35, and 42, respectively, seen in Figure 2.1.
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The identity of the HCA-II was determined by assaying the fractions collected.
The hydrolysis of p-nitrophenyl acetate is a quick and simple assay for the identification
of CA. Para-nitrophenyl acetate is colorless, and the product, p-nitrophenol, is bright
yellow (ε405nm =18,000 M-1cm-1.)96 A 20 mM stock solution of p-nitrophenyl acetate in
acetonitrile is stable for months if stored away from light at 4 oC. Since the molar
absorptivity of p-nitrophenol is so high and p-nitrophenyl acetate reacts so quickly with
CA, very little of the stock (10 μL) is needed to qualitatively identify the fraction
containing CA quickly.
The purity of HCA-II was verified with SDS-PAGE. After the appropriate
fractions, which turned yellow immediately, were collected, they were diluted with 18
MΩ water and run on SDS-PAGE. Fractions were diluted in this manner because the
high salt concentration resulting from the buffered solution causes smearing of the bands
on SDS-PAGE. Care was also taken to reduce the “smiling” effect of the bands by
making sure there were no bubbles attached to the bottom of the gel before and during the
electrophoresis.126 The standard ladder against which the molecular weight of the protein
was determined is the BIO-RAD Precision Plus Kaleidoscope. A typical gel is illustrated
in Figure 2.3. From this gel, one can see that the band indicating the HCA-II is relatively
concentrated (darkly colored) and pure (no other bands are observable.) The
concentration of HCA-II was measured on a Modernized Cary 14 UV/Vis/NIR
Spectrophotometer [Olis, Inc.] using the accepted molar absorptivity, ε280nm = 54,000 M-1
cm-1.43,64,73,110,127,128
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2.2.2

Preparation and characterization of apo-HCA-II and M-HCA-II
For all M-HCA-II derivatives used, including Zn-HCA-II (the wild-type), the

purified wild-type was first converted to apo-HCA-II before producing the M-HCA-II
needed for assays. Because (i) the affinity of HCA-II for Zn2+ is lower than the affinity
of HCA-II for Cu2+ and near that for Fe2+/3+ and (ii), as described in Section 2.1.3, the
metal content of the cell culture media was not highly regulated, the wild-type HCA-II
described above was inevitably composed of a significant concentration of a variety of
M-HCA-II derivatives. A significant portion of the HCA-II isolated was also metal-free
(apo-HCA-II.) It is not known if HCA-II lost its metal during the purification, but >30%
of the prepared HCA-II was consistently apo-HCA-II. (At best 60% of the HCA-II was
Zn-HCA-II.) Therefore, to generate a consistent stock of Zn-CA even the Zn-HCA-II
was prepared from apo-HCA-II for which the metal content was known to be negligible.
The preparation of the apo-HCA-II is straightforward. The wild-type HCA-II was
dialyzed against 50 mM 2,6-pyridine-dicarboxylic acid (dipicolinic acid, DPA) in 50 mM
ACES buffer, pH 6.5, at 4 oC for forty-eight hours. The reduced pH is necessary to
facilitate the chelation and removal of the metal cofactor from CA.38,39 I believe it is
important to note that the dialysis solution was adjusted to 4 oC before addition of the
protein because a too fast, drastic change in the temperature of apo-HCA-II (40% of the
wild-type) leads to quick, irreversible precipitation of the protein.
After this dialysis, the apo-protein was concentrated and prepared for metal
analysis. After concentration by centrifuge filtration, the concentration of apo-CA was
determined on the Cary 14. The molar absorptivity of HCA-II at 280 nm is invariant in
the absence and presence of a metal cofactor and invariant in regards to the identity and
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stoichiometry of the metal cofactor present.40,41,43,47 The concentration of the apo-CA
was taken at this point in order to prepare atomic absorption spectrometry (AAS)
samples. In converting between the molarity of the protein (given by the molar
absorptivity) and concentration of the metal in ppm (used for AAS samples), the identity
of the metal needed to be taken into consideration, due to the nature of ppm values. As
such, 15.3 μM Zn-HCA-II = 1 ppm Zn, 15.7 μM Cu2-HCA-II = 1 ppm Cu, 18.0 μM FeHCA-II = 1 ppm, 17.0 μM Co-HCA-II = 1 ppm, 18.2 μM Mn-HCA-II = 1 ppm Mn, 17.0
μM Ni-HCA-II = 1 ppm Ni. In a typical analysis, apo-HCA-II sample was prepared to be
40 μM, so metal content could be determined at percent incorporations lower than 5% (as
low as 0.1 ppm) as determined from the standard curve for each metal. A representative
standard curve including the error (taken as plus or minus the standard deviation) is
shown in Figure 2.4. The typical concentrations of contaminant metals present in the
wild-type Zn-HCA-II prior to chelation and the apo-HCA-II are listed in Table 2.1.
Table 2.1
Metals
Zn
Fe
Cu
Mn

Metal content of purified Zn-CA and apo-CA
ZnCA (19.98 μM)
[metal] (μM) % metal in ZnCA
5.39 ± 0.03
27.00 ± 0.15
1.592 ± 0.011
7.99 ± 0.06
0.153 ± 0.005
0.77 ± 0.05
0.131 ± 0.002
0.655 ± 0.010
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ApoCA (40.00 μM)
[metal] (μM)
% metal in ApoCA
2.30 ± 0.05
5.76 ± 0.13
0.91 ± 0.05
2.29 ± 0.13
0.275 ± 0.006
0.688 ± 0.015
Below Detectable Levels

Below Detectable Levels

Figure 2.4

Absorbance vs. [M2+] standard curve by AAS

Atomic absorption spectroscopy standard curve. All solutions were prepared with 18
MΩ water and acidified to give solutions in 15 % nitric acid to assure metal solubility.
Solutions were then sonicated and filtered with 45 μm filters. [All points are
representative of the average of five replicates.] (Zn, ; Cu, ; Fe, ; Mn, )
One final note about the AAS samples, all solutions (samples and standards) were
diluted with H2O (18 MΩ) and 70 % HNO3 to give a final acid concentration of 15 %
HNO3, which served to maintain the solubility of the metals in solution by preventing
insoluble metal hydroxides and carbonates from forming in the aqueous solutions. As for
the protein sample, the protein had to be added in the following order due to the rapid
precipitation caused by the HNO3 and the subsequent adherence of the precipitated
protein to the walls of the container. First the HNO3 was added to an appropriate
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quantity of water, and the protein was added to this acid solution. Though the protein
still precipitated, it did not adhere to the walls of the container when added in this order.
The precipitated protein solution was then sonicated at 40 oC for two minutes in an effort
to ensure the metal content was liberated from the protein precipitate. Finally, all the
solutions were filtered in 0.2 μm, polyethersulfone, syringe filters [VWR International,
LLC].
Once the metal content of the apo-HCA-II was known, I titrated metal salt
solutions into aliquots of the apo-HCA-II at the appropriate concentrations to produce the
metal:protein ratios with metals in slight excess. Salts and ratios are listed in Table 2.2. I
chose to add the metals in excess in an effort to overcome the equilibrium that exists in
the binding of the metals with the buffer. In order to account for any activity by the free
metal or metal-buffer complex, metal-buffer solutions were used as controls in every
assay. If not explicitly mentioned, there was no detectable activity due to the free metals
or metal-buffer complexes. Finally, after adding the metal solution to the apo-HCA-II,
the solutions were incubated at 4 oC for a minimum of two hours. As has been reported
by Lindskog, the concentrated Cux-HCA-II and Co-HCA-II solutions were noticeably
colored. The Co-HCA-II was clearly purple. Lindskog described the color similarly as
“reddish blue” in an effort to reinforce his description of the “red shift” he observed:
visible absorbance, approximately 450-680 nm; λmax = 553 nm, ε553nm = 290 M-1 cm-1.38
As for the Cu2-HCA-II, my protein appears to be a very light green-blue color, and
Lindskog describes it simply as “a visible greenish color”: absorbance, 600-<1000 nm;
λmax = 760 nm; ε760nm = 120 M-1 cm-1.38 The other M-HCA-II derivatives share the
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reddish-yellow color that is similar to Zn-HCA-II, although apo-HCA-II has a noticeably
less intense reddish-yellow color.
Table 2.2

Final CA-to-metal concentrations of pure apo-CA
M-CAs
ZnCA
FeCA
Cu2CA
MnCA
NiCA
CoCA

[CA] (mM)
2.84
3.94
3.97
3.97
3.97
3.97
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[M2+](mM)
3.50
4.95
8.74
4.77
4.77
4.77

CHAPTER III
CATALYSIS: WILD-TYPE AND METAL-SUBSTITUTED HUMAN CARBONIC
ANHYDRASE-II DERIVATIVES AND ASSAYS

As discussed in section 1.4.4, only two reports on the native activity of metalsubstituted HCA-II have been reported.9,68 Generalizations are commonly made
extrapolating the activity of M-HCA-II from data describing the activities of M-HCA-I
and M-BCA, but there are also a number of reports detailing discrepancies between the
activities of HCA-I, BCA, and HCA-II, which make such extrapolations suspect.
Presented here are the results of the investigation into the reactivity of Mn2+-, Co2+-, Ni2+, Fe3+-, and Cu2+-HCA-II, all with an average of less than 5% Zn2+ contamination.
Reactivities studied include the hydrolysis of CO2, the hydrolysis of p-nitrophenyl
acetate, the catalytic disproportionation of hydrogen peroxide, and the catalytic
disproportionation of superoxide.
3.1

Native, traditional carbonic anhydrase assays

3.1.1
3.1.1.1

Hydrolysis of CO2
Background
The reversible hydration of CO2 by the wild-type HCA-II has been described

many times, but it is Raja G. Khalifah’s work published in 197136 while he was at
Harvard University which is still considered to be the definitive description of the
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kinetics of this reaction,1 and it is indeed insightful and meticulous in detail. There is
nothing in the characterization of the native activity of HCA-II that I can add to
Khalifah’s work. Although Khalifah’s method of data analysis was not used herein
explicitly, I believe that it is necessary to revisit it here because the reader will find that
an understanding of this method, the implications it leaves, its subtleties, and even
explicit statements will quicken the understanding that future students who will continue
my work.
Because this hydrolytic reaction (Reaction 3.1) is characterized by proton release
into the buffer (Reaction 3.2), it is important to know how the ionization state of the
buffer is affected by proton release (or uptake). If the assay solution contains molecules
whose ionization state is affected by pH (e.g. buffer, pH indicator, weak acids or bases
used to maintain ionic strength), the buffer factor (Q) is used to correlate the proton
release (from the actual reaction of interest) to the method of detection (e.g. pH
measurement or indicator color change) used to characterize that proton release. The
buffer factor can be thought of as a correction factor that accounts for the changing
ionization state of the media molecules during the reaction and relates the method of
detection to the actual enzymatic proton release. Since the hydrolytic activity of HCA-II
is generally followed by the change in absorbance of an acid/base indicator, only this
method of detection will be discussed here. It is important to note that Khalifah’s method
works because the Q of his buffer/indicator systems is pH independent, which is
accomplished by selecting a buffer and indicator that share an identical pKa.
Prior to Khalifah’s work, Q was determined by titrating the assay media129,
including all but the substrate and enzyme, with a standardized acid solution. A linear
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plot of the absolute value of the change in absorbance versus molarity of acid gives Q as
the reciprocal of the slope. Khalifah’s method involved the determination of Q from the
actual assay data, which he rightly says is superior because Q and the assay data are
collected under exactly the same experimental conditions. He also shows that the
concentration of the substrate can be determined from the plot of |ΔAbs| versus proton
release, which can be determined from the data collected with his method. There are two
final notes about |ΔAbs|. First, the absolute value of the change in absorbance must be
taken because the reaction is followed by the quenching of the λmax of the indicator, but Q
must be positive in calculating the initial rate of reaction as seen later. Second, the
reaction must be allowed to reach equilibrium since the total change in absorbance from
the start (t0) to completion is used. This is because the total change in absorbance is
related to [HCO3-]f and the extent of conversion. With this data, the absorbance can be
simply related to the equilibrium expressions for the hydrolysis of CO2 and the ionization
of the buffer, as described below.
In Khalifah’s method, Q is the slope of the linear plot of the equilibrium
concentration of bicarbonate ([HCO3-]f) versus |ΔAbs|. If [CO2]o calculated from the
solubility coefficient of CO2 for an aqueous solutions of known ionic strength, which is a
common method along with an incredibly inconvenient titration with Ba(OH)2, then the
calculation of [HCO3-]f provides a convenient method to validate the calculated [CO2]o in
the following way. [HCO3-]f is calculated along with other necessary parameters by
considering two equilibrium expressions: the hydrolysis of CO2 and the ionization of the
buffer. As for the ionization of the buffer, both the deprotonation and the protonation
expressions will work.
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CO2 + H2 O ⇌ HCO-3 + H+

Reaction 3.1

HB ⇌ H+ + B

Reaction 3.2

𝐾1′ =
′
𝐾𝐻𝐵
+ =

[𝐻 + ]𝑓 [𝐻𝐶𝑂3− ]𝑓

[𝐻 + ]𝑓 [𝐵]𝑓
[𝐻𝐵+ ]𝑓

[𝐶𝑂2 ]𝑓

=

[𝐻 + ]𝑓 ([𝐵]𝑜 −[𝐻𝐶𝑂3− ]𝑓 )
([𝐻𝐵+ ]𝑜 +[𝐻𝐶𝑂3− ]𝑓 )

Equation 3.1
Equation 3.2

With Equation 3.1 [HCO3-]f can be calculated only after [CO2]o is calculated from
the aforementioned solubility coefficient in the common way with the quadratic equation.
Relating [HCO3-]f to the states of ionization of the buffer, allows Equation 3.2 to be
rearranged in such a way that [HCO3-]f can be calculated independently of [CO2]o. The
relationship between [HCO3-]f and the ionization states of the buffer also allows for the
derivation of Equation 3.3 by eliminating [H+]f by rearranging Equation 3.2 and
substituting that into Equation 3.1, and simplifying the result gives Equation 3.3, which is
easily rearranged into Equation 3.4.
𝐾1′ =

′
𝐾𝐻𝐵
([𝐻𝐵+ ]𝑜 +[𝐻𝐶𝑂3− ]𝑓 )[𝐻𝐶𝑂3− ]𝑓

∴ [𝐶𝑂2 ]𝑓 =

[𝐶𝑂2 ]𝑓 ([𝐵]𝑜 −[𝐻𝐶𝑂3− ]𝑓 )
′
𝐾𝐻𝐵
([𝐻𝐵+ ]𝑜 +[𝐻𝐶𝑂3− ]𝑓 )[𝐻𝐶𝑂3− ]𝑓

𝐾1′ ([𝐵]𝑜 −[𝐻𝐶𝑂3− ]𝑓 )

Equation 3.3
Equation 3.4

Both equilibrium constants are well-defined constants. [HB+]o and [B]o are
calculated with the Henderson-Hasselbach equation using the initial pH, pKa, and initial
buffer concentration. Therefore, Equation 3.4 can be simply solved with the quadratic
equation providing a simple method whereby [HCO3-]f , [H+]f , and [CO2]f can be
calculated without [CO2]o and leading to method for calculating [CO2]o without relying
on the solubility coefficient, since [CO2]o is equal to the sum of [CO2]f and [HCO3-]f.
Together the methods can be used to verify [CO2]o , [HCO3-]f , [H+]f , and [CO2]f.
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Khalifah suggests that a plot of [CO2]o versus [HCO3-]f be used to quickly calculate the
needed parameters for additional experiments.
Once the determination of the buffer factor and [CO2]o are taken care of, there
remains the matter of determining the initial velocity (vo) and the Michaelis-Menten
parameters. With respect to the vo, the hydrolysis catalyzed by HCA-II is so rapid (kcat =
1x106) that following the product formation requires a rapid mixing device such as a
stopped-flow mixer with millisecond resolution. Prior to the development of the stoppedflow UV-Vis after WWI, manometers were used to follow the decreased CO2 pressure
over time.3,130,131 In 1960, Lindskog and Malmström were the first to use a stopped-flow
UV-Vis to follow the kinetics of BCA.37 Just as with Khalifah’s method, the rapidmixing UV-Vis method has become the universally accepted method for following the
CO2 hydrolysis kinetics.
Because the resolution of most stopped-flow apparatuses is around a millisecond,
it is possible to measure with great confidence the change in absorbance occurring over
the first second of the reaction. The fact that many researchers use much less than a half
of a second to determine vo should underscore further the necessity for determining the
aforementioned buffer factor. As long as a very short period of time from to is used to
determine the steady-state vo, the substrate concentration is essentially invariant;
therefore, the rate is constant and the reaction trace (ΔAbs vs. t) is linear, regardless if the
[substrate] is high (zero order) or low (first order). The slope of this plot is vo. This
value is converted to molar units (M/unit time) after it is multiplied by the buffer factor.
Due to the limits in the substrate solubility and the kcat observed for HCA-II, saturating
the enzyme in order to determine the Michaelis-Menten parameters from the non-linear
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plot of vo versus [CO2] is not practical. Because of this, the traditional linear
transformations, abandoned in favor of non-linear regression analysis for the kinetics of
other enzymes, remain the method of choice for analyzing HCA-II kinetic data.
3.1.1.2

Methodology
All aqueous solutions were prepared with water; Milli-Q Academic, EMD

Millipore). Enzymes were prepared and characterized as described in Chapter II. MCAs were prepared with the following metal salts: Zn(NO3)2  6H2O [99.6%, J. T. Baker,
CAS#: 10196-18-6, Lot#: J40655], Cu(NO3)2  xH2O [99.999%, Aldrich, CAS#: 13778-31-9,

Lot#: 83897MJ], Mn(NO3)2  xH2O [99.99%, Aldrich, CAS#: 15710-66-4, Lot#:
29798LJ], (NH4)2Fe(SO4)2  6H2O [≥99.0%, Fluka, 7783-85-9, Lot#: 0001364504], NiCl2


6H2O [24.6%, Sigma, CAS#: 7791-20-0, Lot#: 020M1555], and Co(NO3)2  6H2O

[99.0%, J. T. Baker, CAS#: 10026-22-9, Lot#: 28224]. HEPES [N-[2Hydroxyethyl]piperazine-N’-[2-ethanesulfonic acid], 99.5%, Sigma-Aldrich, CAS#:
7365-45-9] was prepared with Na2SO4 [99.9%, Fischer Scientific, CAS#: 7757-82-6,
Lot#: 995089] to maintain ionic strength in the assay and the pH indicator, phenol red [J.
T. Baker, CAS#: 143-74-8, Lot#: 442717]. The phenol red was purified by precipitation
from an aqueous bicarbonate solution by titration with hydrochloric acid as described by
Orndorff and Sherwood.132 The purified phenol red was bright red, and the melting point
matched the value reported by Orndorff and Sherwood, 180 oC.
As seen in Figure 3.1, stopped-flow rapid mixing devices mix solutions from two
fill syringes. One syringe contained the enzyme (solution 1), and the other contained the
substrate (solution 2). Since the two solutions were meant to be as closely matched as
possible, all of the buffer solution used, 20 mM HEPES and 20 mM Na2SO4 (pH 7.50),
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was taken from the same solution. The substrate solution consisted of the buffer solution,
which was equilibrated with CO2 by bubbling with a diffusion stone for at least two hours
before the assay. The equilibration was maintained during the experiment. Phenol red
was diluted to (200 μM) with the buffer solution, and half of this solution was used to
prepare the enzyme solution containing 5 nM M-CA solution (i.e. solution 1). The
equilibrated CO2 solution was diluted with the second half of the phenol red solution to
give a series of substrate concentrations (i.e. solution 2): 10.01 mM, 11.9 mM, 12.6 mM,
13.3 mM, 14 mM, 14.7 mM, 15.4 mM, 16.1 mM, 16.8 mM.

Figure 3.1

Stopped-flow UV-Vis apparatus
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Immediately before every reaction the required, diluted CO2 solutions were
prepared, reducing the loss of CO2 from the solution. The concentration of CO2 in the
equilibrated, stock solution was calculated using Henry’s Law.133,134
C = kHCO Pgas
2

, where kHCO = 0.035
2

mol
kg bar

at 25o C

Equation 3.5

The variable C is the molal concentration of the gas, kH is Henry’s law constant,
and Pgas is the partial pressure (bar) of the gas above the solution. Therefore, the
concentration of CO2 in solution was calculated to be 0.035 M. The ionic character of the
solution and a small deviation from STP in the temperature of the buffer or atmospheric
pressure during the experiment makes very little difference in the calculation of the CO2
concentration according to values published by Edsall and Wyman.134
3.1.1.3

Data and discussion
There are only two peer-reviewed articles which report the rate of hydrolysis of

CO2 by M-HCA-II (i.e. Co-HCA-II and Cux-HCA-II).39,52 In addition, Lindskog
published a review in 1982 wherein he included “unpublished data” describing the
activity of Cd-HCA-II.59 I believe that the initial bias against using HCA-II is due to its
lower abundance in the body, which has led others to collect the data representing the
activity of M-CA with M-BCA and M-HCA-I. Another issue with previously reported
M-CA values is that these values have not been revisited since the 1960s – well after
Khalifah’s effort to standardize the methods and conditions under which this activity is
measured.36 This means that the buffer system, ionic strength of the solutions, pH,
temperature, and acid/base indicator vary among the different reports. Lindskog even
went so far as to include in his buffer solution a chelator, 1,10-phenanthroline, equimolar
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to his enzyme.39 This would have the effect of chelating weakly bound metals (i.e. Mn2+,
Co2+, Ni2+, and Fe2+) from the protein during the assay.
Herein, I report that the hydrolysis of CO2 catalyzed by M-CA, which has a
higher reactivity than previously reported. However, Co-CA gave values in agreement
with previous reports.39,42 Table 3.1 lists the activities of M-CA and the conditions under
which those data were collected. Table 3.1 also lists metal-binding constants reported by
Lindskog to have been collected with HCA-I at pH 5.5.39
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Table 3.1

Metal-binding constants and relative rates of hydrolysis of CO2 by metalsubstituted human carbonic anhydrase

% Relative Activity
Metal- % Relative Activity
*
(measured)
(literature values)
Binding
M-CAs
Ref.
Constant % activity
Temp.
Temp.
pH o
% activity isomer pH
(log Ka) (HCA-II)
( C)
(oC)
water blank
-0
7.5 23
-----42§
Apo-CA
----3.92% HCA-I -0-4
100%
BCA 8.2 1.0-1.5 39
42
Zn-CA
9.3◊ 100.0 ± 1.3 7.5 23
100% HCA-I -0-4
42
100% HCA-II -0-4
50%
BCA 8.2 1.0-1.5 39
55%
HCA-I 8.2 1.0-1.5 39
Co-CA
7.2†
47.5 ± 0.6 7.5 23
50% HCA-II 8.2 1.0-1.5 39
42
56%
HCA-I -0-4
0%
BCA 8.2 1.0-1.5 39
52
Cux-CA‡
11.6† 67.5 ± 1.1 7.5 23
10% HCA-II 7.4
25
42
1.25% HCA-I -0-4
2%
BCA 8.2 1.0-1.5 39
†
Ni-CA
9.5
69.7 ± 0.6 7.5 23
5%
HCA-I 8.2 1.0-1.5 39
42
4.9% HCA-I --2+
4% (Fe ) BCA 8.2 1.0-1.5 39
Fe-CA
-59.5 ± 0.7 7.5 23 5% (Fe2+) HCA-I 8.2 1.0-1.5 39
38
0% (Fe3+) BCA 8.2
4-8
8%
HCA-I 8.2 1.0-1.5 39
Mn-CA
3.8†
69 ± 3 7.5 23
12%
BCA 8.2 1.0-1.5 39
42
3.92% HCA-I -0-4
Cu/Zn-CA
-86 ± 4 7.5 23
-----59
2%
HCA-II
8.5
25
Cd-CA
9.2†
--- 23
42
4.22% HCA-I -0-4
†
42
Hg-CA
21.5
--- 23
0.05% HCA-I -0-4
*
For reaction conditions, see section 3.1.1.2. [All reported values are representative of
the average of five replicates.]
†
Measured for M-HCA-I at pH 5.5.39
◊
Buffer and pH independent value.135
‡
Measured values are reported for Cu2-CA. Literature values appear to be for Cu1-CA,
according to reported methods.
§
Coleman reports values collected from the Wilbur and Anderson method, which
determines activity by measuring the change in pH during the reaction. The pH is
allowed to fluctuate between pH 6-8.
The measured rates listed in Table 3.1 and illustrated in Figure 3.2 show that ZnCA and Cu/Zn-CA have much higher rates of catalysis than the other M-CA. The high
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rate of hydrolysis of Cu/Zn-CA can easily be explained when considering that its activity
must be almost entirely due to the presence of Zn2+ in the CA active site. There are two
binding sites for Cu2+ in HCA-II,52,69,70 and the high affinity binding site for Cu2+ in
HCA-II is not the Zn2+-binding site (i.e. the active site.)68 The Cu2+ is bound in a site
13.6 Å away from the active site Zn2+ metal center.68 This means that titrating Zn-CA
with one equivalent of Cu2+ does not displace the Zn2+ from the active site, nor does it
disturb the structure or electronics of the active site enough to cause greater than about
15% inhibition of the native rate.

Figure 3.2

Normalized rate of hydrolysis of CO2 by M-HCA-II

The different colors represent Zn-CA, red; Cu2-CA, green; Cu/Zn-CA, yellow; Fe-CA, dark blue; Mn-CA,
pink; Ni-CA, light blue; Co-CA, gray; and the blank (i.e. no CA), black. Enzyme solutions consisted of a
20 mM HEPES/ 20mM Na2SO4/ 200 μM phenol red buffer solution at pH 7.50 and 5 nM M-CA. Substrate
buffer solutions were matched with the above buffer with which a CO2-equilibrated buffer solution (as
above without phenol red) was diluted at various concentrations. Substrate and M-CA concentrations were
halved in the stopped-flow mixer before measuring the reaction rate. The inset has a larger range over both
the x-axis and y-axis for the same data.
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As discussed in Chapter I, the hydrolytic mechanism and structure of CA are well
understood. With respect to the mechanism, the function of the Zn2+ center is to lower
the pKa of the Zn2+-bound water molecule, thereby facilitating the formation of the Zn2+bound hydroxide.36,73,75 In theory any divalent metal ion that can also bind a water
molecule and lower its pKa near that of the Zn2+-bound water molecule should maintain
the activity of CA.72
With respect to the structure of M-CA, crystal structures70 and exhaustive
spectroscopies60 of M-CAs have been reported for many years. The active site of M-CA
is known to be flexible, but rigid enough not to disturb the surrounding residues’
orientation.1 The only exception to this is Hg-CA, wherein Hg2+ directly binds His64
inhibiting all activity.84 Considering the mechanism of CA and the variations in the
structures of M-CA, it is reasonable that most M-CAs maintain some activity; however,
the physical properties distinct to each of the metals must also be considered. The ligand
exchange rate, the hardness, the extent to which the metal can lower the pKa of water, and
the susceptibility to chelation are a few properties that may effect the activity of M-CA.
Common ligand exchange rates, listed in Table 3.2, show that only Ni2+ has an
anomalously low exchange rate.72 The ligand exchange rates for Fe2+, Co2+, and Mn2+
are similar to Zn2+ suggesting that the substrate and/or product rate of dissociation will
not be an obstacle to the substituted metals exhibiting hydrolytic catalysis, whereas the
exchange rate for Ni2+ could contribute to the lower activity of Ni-CA. Interestingly, the
higher exchange rate of Cu2+ should support the activity of Cu2CA; however, there are
obviously other properties preventing it from being more active.

46

Table 3.2

Ligand-exchange rate of select, divalent transition metals72
M2+
Zn2+
Cu2+
Mn2+
Fe2+
Ni2+
Co2+
Fe3+

k (sec-1)
2 x 107
1 x 109
2 x 107
4 x 106
4 x 104
3 x 106
2 x 102

For the most part the hard/soft nature of these metals ion does not differ
dramatically.72 Fe2+, Ni2+, Co2+, Cu2+, and Zn2+ are all considered to be “intermediate”
with respect to their hard/soft nature. This means that the coordination between these
metals and the imidazolium rings of the 3His coordination sphere forms strong coordinate
covalent bonds with all of these metal ions. Mn2+ is a hard metal, however, which likely
contributes to the lower metal-binding constant for Mn-CA, listed in Table 3.1.
For the hydrolytic mechanism of CA, it is important that the metal center lowers
the pKa of the metal-bound water, thereby allowing the deprotonation of the water by
His64. The pKa of water (15.4) is effectively lowered by free Zn2+ to 10.0.72,136 When
coordinated to CA, the protein framework further facilitates the decrease in pKa such that
the accepted pKa of Zn-OH2/OH- in HCA-II is 6.8.1,32 The pKa values for M-HCA-II
have not been reported, so the precise extent to which Fe2+, Mn2+, Co2+, Ni2+, and Cu2+
can lower the pKa when coordinated is unknown. Mn2+ and Cu2+ are known to lower the
pKa of a bound water (Cu2+-OH2, pKa is 10.7. Mn2+-OH2, pKa is 11.1.72) but to a lesser
extent than the free Zn2+.
The expanded geometries favored by the substituted metals increase the extent to
which these metals are bound by adventitious anions in solution.72 These anions can
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include halides and other small anions added during titration of the buffer, anions added
to the solution to maintain ionic strength, and the buffer molecules
themselves.41,43,46,54,85,127,137-142 Many anions and buffers (i.e. CN-, Cl-, tris, acetate, etc.)
have been shown to either bind the metal center in crystal structures and/or inhibit their
activity. The relative susceptibility of each metal to coordination by these anions is also
indicated by the Irving-Williams series, which is arranged by increasing susceptibility:
Ca2+ < Mg2+ < Mn2+ < Fe2+ < Co2+ < Ni2+ < Cu2+ > Zn2+.72 This trend indicates that Cu2+
and Zn2+ form the strongest interactions with anions.
Taking the ligand-exchange rates, Irving-Williams series, and coordination
geometries together, one can begin to explain the discrepancy between the activity of ZnCA and Cux-CA as well as the lack of activity of Cux-CA reported in the literature. The
geometry of the active site of CA, facilitated by the H-bonding network and residues
within and outside of the first coordinaton sphere, promotes a tetrahedral geometry, and
Zn2+ can easily accommodate this as a d10 metal with the bound water/hydroxide and the
properly oriented His94, 96 and 119 residues in the active site. As for Cu2-CA, the active
CuB-CA site exists as a distorted trigonal bipyramidal coordination (Figure 1.5), which
leaves open coordination sites after binding the water/hydroxide and three His residues in
the active site. (CuB-CA refers to the copper atom bound in the low affinity site, the
native active site, within Cu2-CA.) These available coordination sites, the greater ligandexchange rate for Cu2+, and the position of Cu2+ within in the Irving-Williams series
makes the CuB-CA site more susceptible to small molecule binding and inhibition.
As for the other M-CAs, only the geometries of Co-HCA-II, Mn-HCA-II, and NiHCA-II have been determined.1,70 Co-HCA-II (Figure 1.5) is reported to exist in a
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tetrahedral geometry, which helps to explain why it maintains its activity. As discussed
previously, the molecular oxygen in the Co-HCA-II crystal may indicate that Co2+ can
adopt an expanded geometry as well, and Co2+ is known to adopt an octahedral geometry
as well, which may explain its limited activity.72 It has been reported that Mn-HCA-II
has an octahedral geometry, but this HCA-II was reconstituted with MnSO4, and the
sulfate ion is observed as a bidentate coordinating ligand in the structure. The two labile,
facial coordinate positions around the octahedral Mn-HCA-II are occupied by the sulfate
ion itself. It is reasonable that the sulfate can act as a tridentate ligand for the Mn2+ in
competition with the bound water, which would effectively limit any hydrolytic activity.
As for Ni-HCA-II, a crystal structure with an octahedrally coordinated Ni2+ has been
reported.70 As a small d8 metal, Ni2+ can stabilize an octahedral environment, but with
the expanded coordination (as opposed to the square planar geometry typically seen of
Ni2+ coordination) the ability of Ni2+ to lower the pKa of a coordinated water molecule
could be reduced enough to limit activity. As for Fe-CA, its geometry has yet to be
reported. The need to use fresh or anaerobic Fe-CA may have lead to reports of
inactivity by Fe-CA. The propensity for the oxidation of Fe2+ and the ligand-exchange
rate of Fe3+ (much lower than the other metals) are serious problems in efforts to
determine a structure and in reporting the activity of Fe-CA.
The properties described pose obvious challenges that need to be considered or
addressed when reporting M-HCA-II activity. In addition to these issues, the long
standing convention of generalizing the data collected with M-HCA-I or M-BCA to MHCA-II has led to assumptions about M-HCA-II activity which seem unjustified. The
structure of HCA-II was shown to differ from HCA-I and BCA. The pKa of the Zn2+49

bound water was shown to be 6.8 for HCA-II,143 8.1 for HCA-I,43 and in the range 6.4-7.1
for BCA-II.144-146 In addition, EPR and NMR spectroscopy have both shown that the
structures and metal coordination sites within the various isomer differ, which can help to
explain differences in activities among the isomers of CA;45,47,49,50 however, little
investigation has been invested in M-HCA-II.
Finally, with respect to Cux-CA, previous studies report sub-stoichiometric
titrations of Cu2+ into apo-CA, indicating the use of CuA-CA. (CuA-CA is CA with Cu
occupying the high affinity binding site, not the native active site.)39,41-43,47 With the first
report of the second, high affinity binding site (site A) of Cu2+ in HCA-II, the activity
collected for Cux-CA became suspect.70 As discussed, the high affinity site is not the
Zn2+-binding site (site B); therefore, the native activity that results from substituting Cu2+
into the Zn2+-binding site has not been clearly reported. Only one of the three reports of
Cu2-CA has reported on activity. This study from the Emerson lab reports only the nonnative oxidation of 2-aminophenol by Cu2-CA.68 The data presented in Table 3.1 is the
first reported native activity of Cu2-CA.
3.1.2
3.1.2.1

Hydrolysis of p-nitrophenyl acetate
Background
Esterase activity, i.e. the hydrolysis of different esters – most commonly p-

nitrophenyl acetate, was first described by Shaw, Syner, and Tashian in 1962.147 In fact,
they credited the activity to a “new erythrocyte esterase” in humans. A year later Tashian
reported that they had fully and accurately characterized the “new esterase” and
determined it to be HCA.148 This was only the first “new” substrate found for CA, and it
has since become the most common substrate used to test for CA activity.
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Because the hydrolysis of p-nitrophenyl acetate (Reaction 3.4) is simple to
follow, in contrast to the complex analysis required to interpret data collected from the
hydrolysis of CO2 (Reaction 3.3), it is more common to see this activity reported than the
hydrolysis of CO2. The esterase activity can be directly monitored by following the rate
of appearance of the colored product, p-nitrophenol (ε405nm = 18,000 M-1cm-1) at 405 nm.
The initial velocity is taken as the Δ[p-nitrophenol]/time after converting the ΔAbs to
Δ[p-nitrophenol]. Michaelis-Menten parameters have previously been reported for this
activity for Zn-HCA-II only once,32 and some have pointed out problems associated with
these parameters due to the limited solubility of p-nitrophenyl acetate in aqueous
solutions and the inhibition of activity found at high concentrations of pnitrophenol.32,36,110 As is the accepted convention, it is my primary interest here to
describe the differences in the apparent parameters when comparing the metal-substituted
HCA-II derivatives, not to report the absolute parameters.
CO2 + 2H2 O ⇌ HCO-3 + H3 O+

Reaction 3.3

Reaction 3.4
3.1.2.2

Methodology
Details of the water purification system and most of the chemicals used are listed

in section 3.1.1.2. A description of the purification of CA can be found in Chapter II.
For this assay, p-nitrophenyl acetate [99%, Sigma, CAS#: 830-03-5, Lot#: 057K2614]
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was prepared in neat in acetonitrile [99.9%, Fisher Scientific, CAS#: 75-05-8, Lot#:
073936]. The solid p-nitrophenyl acetate was stored at -80oC, and the substrate solution
was stored at 4 oC. Since the solution is prepared without water, this stock solution is
stable with no discoloration for months. Nevertheless, this solution was mixed freshly
for each set of experiments.
This assay was followed with the stopped-flow apparatus; so two solutions were
prepared for rapid-mixing experiments. The M-HCA-II solution consisted of an aqueous
solution of 20 mM HEPES (pH 7.5), 20 mM Na2SO4, and 600 nM M-HCA-II. The ester
solution consisted of an aqueous solution of 20 mM HEPES (pH 7.5), 20 mM Na2SO4,
and varying concentrations of p-nitrophenyl acetate: 51.0 μM, 98.9 μM, 201.1 μM, 390
μM, 810 μM, 1.20 mM, 1.41 mM, 1.80 mM, 2.49 mM, and 4.98 mM. The solutions were
matched as described in section 3.1.1.2. The rate of product (p-nitrophenol) formation
was followed at 405 nm for 15 seconds at 64 scans/second. Approximately 40% of data
collected (i.e. 384 scans) was taken to represent the linear, initial rate of conversion. The
discarded portion of the data, contained significant noise due to mixing turbulence, or it
showed dramatic product inhibition. Our lab has observed the inhibition of CA by pnitrophenol by stopped-flow and by following the kinetics by isothermal titration
calorimetry. These data are not yet published.
3.1.2.3

Data and Discussion
The hydrolysis of p-nitrophenyl acetate is currently the most commonly used

assay for the measure of CA activity. As discussed, the assay is simple to perform and
analyze, yet there are many parameters to account for in this assay – parameters which
may be of less concern when performing the hydrolysis of CO2 assay.
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There have been a number of reports presenting the relative activities of M-CA in
hydrolyzing p-nitrophenyl acetate. Table 3.3 lists our data for M-HCA-II along with a
number of M-CA activities taken from the literature. Generally, the relative activities of
M-HCA-II agree with that collected for M-HCA-I and M-BCA, with the exception of the
anomalously high activity of Co-HCA-I and Co-BCA.
Table 3.3

Metal-binding constants and relative rates of hydrolysis of p-nitrophenyl
acetate by metal-substituted human carbonic anhydrase II
% Relative Activity
(measured)*

% Relative Activity
(literature values)

MetalBinding
Constants
(log Ka)

% activity
(HCA-II)

pH

water blank

--

0

7.5

23

Apo-CA

--

--

--

Zn-CA

9.3◊

100 ± 6

Co-CA

7.2†

Cux-CA‡

M-CAs

Temp.
% activity
(oC)

Ref.

isomer

pH

Temp.
(oC)

--

--

--

--

--

--

3.3
0.8

HCA-I
BCA

7.5
7.6

23
25

42

7.5

23

100
100

HCA-I 7.5
HCA-II 7.5

23
23

42

2.55 ± 0.19

7.5

23

322
96.7

HCA-I
BCA

7.5
7.6

23
25

42

11.6†

4±3

7.5

23

18.5
0.7

HCA-I
BCA

7.5
7.6

23
25

42

Ni-CA

9.5†

0.299 ± 0.012

7.5

23

11.9
1.5

HCA-I
BCA

7.5
7.6

23
25

42

Fe-CA

--

0.54 ± 0.06

7.5

23

1.86

BCA

7.6

25

41

3.8

7.5
7.6
--§

23
25
25

42

Mn-CA

HCA-I
BCA
BCA

Cu/Zn-CA
Cd-CA

41

42

41

41

41

0.39 ± 0.03

7.5

23

14.1
4.65
4.5

--

4.7 ± 0.3

7.5

23

--

--

--

--

--

9.2†

--

--

23

7.4
0.6

HCA-I
BCA

7.5
7.6

23
25

42

†

41
149

41

42
Hg-CA
21.5†
--23
3.3
HCA-I 7.5
23
*
Enzyme solutions consisted of a 20 mM HEPES/ 20mM Na2SO4 buffer solution at pH 7.50 and 600 nM
M-CA. Substrate buffer solutions were matched with the above buffer with which a stock solution of pnitrophenol acetate in neat acetonitrile was diluted at various concentrations. Para-nitrophenol acetate and
M-CA concentrations were halved in the stopped-flow mixer before measuring the reaction rate. [All
reported values are representative of the average of five replicates.]
†
Measured for M-HCA-I at pH 5.5.39
◊
Buffer and pH independent value.135
‡
Measured values are reported for Cu2-CA. Literature values appear to be for Cu1-CA, according to
reported methods.
§
Lanir did not report the pH at which the assay was performed.
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Apart from the oft-cited relative activities of CA for this activity, there has only
been one report presenting the Michaelis-Menten parameters for this catalysis by CA. In
1967, Verpoorte et al. reported the Km and kcat for this reaction.32 The data listed in Table
3.4 were taken from the data in that report. Within that report as well, Verpoorte et al.
began a discussion about the nature of the assay and the p-nitrophenyl acetate substrate
itself not lending themselves to a determination of the Michaelis-Menten kinetic
parameters.
Table 3.4

Michaelis-menten kinetic parameters for the hydrolysis of p-nitrophenyl
acetate by human carbonic anhydrase II*32

Ionic Strength
KM
kcat
kcat /KM
pH
(mM)
(mM)
(sec-1)
(mM-1s-1)
13.84
6.99 22 ± 5 40 ± 10
2±1
18.63
8.00 21 ± 5 50 ± 10
3±1
19.84
8.98 24 ± 5 60 ± 10
2±1
Verpoorte reports that all data were collected under the following conditions - 0.01 M
diethylmalonic acid buffer with 0.67% (v/v) acetone using 0.2-0.7 µM HCA-II.
*
Since error was not explicitly reported for these values, I calculated all error values from
data available within the report.
According to the authors, the limited solubility of p-nitrophenyl acetate in
aqueous solutions prevents the saturation of the enzyme. The concentration of the
substrate is necessarily much lower than the KM. Therefore, in order to estimate the KM
and kcat, one needs to extrapolate from the collected data at such length that the accuracy
of the estimation is too greatly reduced to be useful. They assert that this large error is at
its greatest in estimating these parameters for HCA-II. Nevertheless, they presented their
estimates (Table 3.4) along with the conditions under which they were taken, and I
present those values along with the data I have calculated in Table 3.5.
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Table 3.5

Michaelis-Menten kinetic parameters for the hydrolysis of p-nitrophenyl
acetate by M-HCA-II

Ionic
kcat/KM
M -CA Strength pH KM (mM) Vmax (μM s-1)
kcat (s-1)
(mM-1 s-1)
(mM)
Zn-CA
65
7.5
2.0 ± 0.3
19 ± 3
32 ± 5
16 ± 5
Cu2-CA
65
7.5
1.2 ± 0.4 0.067 ± 0.018 0.11 ± 0.03 0.09 ± 0.06
Cu/Zn-CA
65
7.5 1.50 ± 0.19 0.81 ± 0.10
1.35 ± 0.17
0.9 ± 0.2
MnCA
65
7.5
0.9 ± 0.4 0.043 ± 0.016 0.07 ± 0.02 0.08 ± 0.06
CoCA
65
7.5 0.26 ± 0.06
0.22 ±0.04
0.33 ± 0.06
1.3 ± 0.5
FeCA
65
7.5
BDL*
NiCA
65
7.5
BDL*
Enzyme solutions consisted of a 20 mM HEPES/ 20mM Na2SO4 buffer solution at pH
7.50 and 600 nM M-CA. Substrate buffer solutions were matched with the above buffer
with which a stock solution of p-nitrophenol acetate in neat acetonitrile was diluted at
various concentrations. Para-nitrophenol acetate and M-CA concentrations were halved
in the stopped-flow mixer before measuring the reaction rate. [All reported values are
representative of the average of five replicates.] (*BDL, below detection limit.)
2+

In addition the problem of substrate solubility, there are four issues which need to
be accounted for since they may drastically effect the rate of hydrolysis of p-nitrophenyl
acetate by M-HCA-II: ionic strength, pH, temperature, and inhibition by organic
solvents.32,56,60,110,150 With no previous reports of the effect of these parameters on MHCA-II, one study of Co-BCA leads to the estimation that these parameters have at least
as great an effect on M-HCA-II as Zn-HCA-II.41 A familiarity with the effect of these
conditions on the activity of CA is needed to interpret the activities of M-HCA-II.
The study of ionic strength varied at constant pH and temperature has been
presented by only Steiner and Lindskog.110 Their data illustrate that doubling the ionic
strength of the solution approximately doubles the catalytic efficiency, kenz, of HCA-II,
where kenz = kcat/Km. In addition, they show the effect of ionic strength on kenz at
different pH values. In identical buffer solutions, at pH 7.5 in a 1 M Na2SO4 solution, log
kenz is approximately 3.7 while this value lowers to about 3.2 without the added salt.
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When the log kenz is measured at pH 8.0 with 1 M Na2SO4, it is approximately 4.0. At
pH 8.0 without salt, log kenz is near 3.4.
Furthermore, the data from Steiner and Lindskog shed light on the influence of
pH at constant ionic strength. His data show how changing ionic strength together with
changing pH effects kenz. Extrapolating from his data show that, without added salt,
changing pH from 6.5 to 8.5 increases kenz by 3.5 times. This change in pH in the
presence of 1 M Na2SO4 causes an increase in kenz by a factor of 8. The data from
another report show that kenz is nearly halved from pH 7.4 to 7.0.41 As for varied
temperatures, Pocker and Sarkanen show that at pH 7.5 and 15oC the kenz is 80 M-1 s-1
while changing the temperature to 25oC causes the kenz to jump to 200 M-1 s-1 with even
greater differences at high pH values.56
Finally, the problem of low solubility of p-nitrophenyl acetate is exacerbated by
the discovery that CA activity is inhibited by the very organic solvents that increase this
solubility. There have been several investigations into the inhibition of CA activity by
water-soluble organic solvents.32,41,82,150-152 Generally, the size of the solvent molecule
and its polarity seem to dictate the magnitude of inhibition with small, polar organic
molecules inhibiting the most.151 These inhibitors were believed originally to inhibit by
displacing water from the active site of CA, but spectroscopic investigations have shown
that they instead bind to the hydrophobic pocket of CA – displacing the substrate (i.e.
CO2 or p-nitrophenyl acetate.)153 Of these organic solvents, small alcohols are the most
commonly reported inhibitors.32,82,152,153
The most common organic solvents used to increase the solubility of pnitrophenyl acetate are acetone and acetonitrile.32,41-43,56,73,82,96,110,111,113,135,153 Thorslund
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and Lindskog reported that acetone inhibits CA to a lesser extent than does acetonitrile
(CH3CN), and since CH3CN was used in this study to solubilize p-nitrophenyl acetate, it
is of greater interest here.41 Pocker and Stone reported that a 10 % (v/v) CH3CN solution
causes a 50 % inhibition of the activity of BCA.82 Safarian et al. went on to further
characterize the interaction between CH3CN and BCA.151 They showed that the presence
of CH3CN destabilizes the tertiary structure of the BCA. As the % (v/v) CH3CN
increases the melting temperature of the protein decreases such that at 47.5% CH3CN the
melting temperature drops from about 70oC to 26oC – nearly room temperature. With the
interactions between BCA and fluorescent probes, they deduced that the tertiary structure
was effected by CH3CN, and circular dichroism showed that the secondary structure
changed very little. Safarian et al. assert that CH3CN should be considered a mild
denaturant for BCA, and he extrapolates from his data that the cause is the ability of
CH3CN to strip away water molecules from the protein structure, which would of course
reduce the function of the critical hydrogen bonding network within the enzyme. He also
notes that the reorientation of the tryptophan residues within the BCA dues to the
presence of CH3CN may cause the decreased enzyme velocity. He shows with a
fluorescent investigation using KI as a Trp quenching agent that upon addition of CH3CN
Trp residues within BCA become more solvent exposed, and Trp4 and Trp190 (local to
the active site) are believed to be two of the Trp residues which reorient. Like many
before, this property of CH3CN may be a source of error in my own data, but it will be
very limited. In my assay solution the CH3CN is less than 1% (v/v) for runs of low [pnitrophenyl acetate], and as the concentration increases to 16.6% in higher [p-nitrophenyl
acetate] runs the linearity seen in my Lineweaver-Burk plots is maintained. (See Figures
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3.3-3.7.) In addition, the value for kenz of HCA-II that I report in Table 3.5 is two orders
of magnitude higher than that reported by Pocker and Sarkanen, 0.55 mM-1sec-1.56

Figure 3.3

Hydrolysis of p-nitrophenyl acetate by Zn-HCA-II

Enzyme solutions consisted of a 20 mM HEPES/ 20mM Na2SO4 buffer solution at pH
7.50 and 600 nM M-CA. Substrate buffer solutions were matched with the above buffer
with which a stock solution of p-nitrophenol acetate in neat acetonitrile was diluted at
various concentrations. Para-nitrophenol acetate and M-CA concentrations were halved
in the stopped-flow mixer before measuring the reaction rate. [All reported values are
representative of the average of five replicates. Error bars represent the standard
deviation of the five replicates.]
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Figure 3.4

Hydrolysis of p-nitrophenyl acetate by Mn-HCA-II

Enzyme solutions consisted of a 20 mM HEPES/ 20mM Na2SO4 buffer solution at pH
7.50 and 600 nM M-CA. Substrate buffer solutions were matched with the above buffer
with which a stock solution of p-nitrophenol acetate in neat acetonitrile was diluted at
various concentrations. Para-nitrophenol acetate and M-CA concentrations were halved
in the stopped-flow mixer before measuring the reaction rate. [All reported values are
representative of the average of five replicates. Error bars represent the standard
deviation of the five replicates.]
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Figure 3.5

Hydrolysis of p-nitrophenyl acetate by Cu2-HCA-II

Enzyme solutions consisted of a 20 mM HEPES/ 20mM Na2SO4 buffer solution at pH
7.50 and 600 nM M-CA. Substrate buffer solutions were matched with the above buffer
with which a stock solution of p-nitrophenol acetate in neat acetonitrile was diluted at
various concentrations. Para-nitrophenol acetate and M-CA concentrations were halved
in the stopped-flow mixer before measuring the reaction rate. [All reported values are
representative of the average of five replicates. Error bars represent the standard
deviation of the five replicates.]
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Figure 3.6

Hydrolysis of p-nitrophenyl acetate by Cu/Zn-HCA-II

Enzyme solutions consisted of a 20 mM HEPES/ 20mM Na2SO4 buffer solution at pH
7.50 and 600 nM M-CA. Substrate buffer solutions were matched with the above buffer
with which a stock solution of p-nitrophenol acetate in neat acetonitrile was diluted at
various concentrations. Para-nitrophenol acetate and M-CA concentrations were halved
in the stopped-flow mixer before measuring the reaction rate. [All reported values are
representative of the average of five replicates. Error bars represent the standard
deviation of the five replicates.]
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Figure 3.7

Hydrolysis of p-nitrophenyl acetate by Co-HCA-II

Enzyme solutions consisted of a 20 mM HEPES/ 20mM Na2SO4 buffer solution at pH
7.50 and 600 nM M-CA. Substrate buffer solutions were matched with the above buffer
with which a stock solution of p-nitrophenol acetate in neat acetonitrile was diluted at
various concentrations. Para-nitrophenol acetate and M-CA concentrations were halved
in the stopped-flow mixer before measuring the reaction rate. [All reported values are
representative of the average of five replicates. Error bars represent the standard
deviation of the five replicates.]
Therefore, due to the limited aqueous solubility of the substrate and the sensitivity
of this assay to changes in ionic strength, changes in pH and temperature, and
destabilization by organic solvents, the reliability of the Michaelis-Menten kinetic
parameters collected from this study have significant error. In rare form for the CA
community, many have expressed this sentiment clearly and consistently.32,36,73,82,110 To
date the only reliable M-M kinetic parameters are collected from the CO2 assay, yet
others have even called those parameters into question due to the inability to effectively
saturate the enzyme at room temperature.129
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Since these conditions and their effects on CA activity cannot be avoided, a strict
adherence to accepted standard conditions, which do not yet exist, would allow for a
better comparison of activity from varied sources. However, since no standard conditions
have been formally presented or accepted by the CA community, a thoughtful, thorough,
and unambiguous reporting of these conditions under which kinetic values for this assay
are measured is required.
3.2

Modeled-enzyme assays
In order to seek out new activities for M-HCA-II, we chose to model the activities

of enzymes with either active site structures similar to HCA-II or with mechanisms which
proceed throughout the activation of some species represented in the oxygen redox cycle.
The active site of CA consists of three histidines bound in a tetrahedral geometry to a
zinc center. Therefore, redox active, non-heme enzymes with histidine rich active site
should provide catalytic processes, which could be modeled by carbonic anhydrase.
3.2.1
3.2.1.1

Oxidation of 2-aminophenol
Background
The oxidation of 2-aminophenol has been used to characterize the activity of

peroxidases like HRP (Reaction 3.5).123 In addition, it was used to characterize Cu2HCAII by the Emerson group.68 Peroxidase enzymes like HRP can activate hydrogen
peroxide which then attacks 2-aminophenol to dimerize two equivalents, forming the
colored product, 2-aminophenoxazinone (ε434nm = 23,200 M-1cm-1).154 The oxidation of
2-aminophenol is followed by the appearance of the product, 2-aminophenoxazinone.
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Reaction 3.5
3.2.1.2

Methodology
Details of the water purification system and most of the chemicals used are listed

in section 3.1.1.2. A description of the purification of CA can be found in Chapter II.
For this assay, 2-aminophenol [99%, AlfaAesar, CAS#: 95-55-6, Lot#: 00017113], the
substrate, was prepared in degassed H2O. The solid 2-aminophenol is stable at room
temperature; however, the stock solution of 2-aminophenol (5 mM) must be made freshly
each day. The stock solution is prepared by diluting 2-aminophenol with degassed H2O
and vortexing for 30 minutes. The limit of solubility of 2-aminophenol in H2O is
approximately 10 mM. The concentration of hydrogen peroxide [50%, Aldrich, CAS#:
7722-84-1] was determined spectroscopically to be 17.9 ± 0.3 M and stored at -20oC.155
The [H2O2] was determined at 240 nm with a Modernized Cary 14 UV/Vis/NIR
Spectrophotometer [Olis, Inc.] (ε240 nm = 43.6 M −1 cm−1 ).
This assay was conducted with the stopped-flow mixing apparatus; two solutions
were prepared for the two syringes. Solution1 consisted of an aqueous solution of 50
mM ACES [N-(2-acetamido)-2-aminoethanesulfonic acid, 99%, GenScript, CAS#: 736582-4, Lot#: C59531302] and 600 nM M-HCA-II. Solution2 consists of 50 mM ACES,
200 μM H2O2, and varying concentrations of 2-aminophenol: 40 μM, 60 μM, 80 μM,
100 μM, 200 μM, 400 μM, 800 μM, 1.6 mM, 2.4 mM, and 2.8 mM. The rate of catalysis
was followed by the production of 2-aminophenoxazinone.
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3.2.1.3

Data and discussion
Of the M-HCA-II variants tested, only Fe-CA and Cu2-CA showed the ability to

activate H2O2 and oxidize 2-aminophenol. The activity of Cu2-CA was previously
reported by the Emerson group.68 That activity is confirmed here with additional kinetic
values, i.e. KM and kcat/KM in Table 3.6 collected from the Lineweaver-Burk plots in
Figures 3.8 – 3.9. The lack of activity from Cu/Zn-CA demonstrates that this activity
results from either the low affinity, CuB site or the combination of both copper sites.
Mutation of the HCA-II to remove the high affinity site would clarify this uncertainty.
Table 3.6

Michaelis-Menten kinetic parameters for the oxidation of 2-aminophenol by
M-HCA-II

M-HCA-II
KM (mM)
kcat (s-1)
kcat/KM (mM-1s-1)
Fe-CA
0.39 ± 0.07
1.4 ± 0.3
3.6 ± 1.4
Cu2-CA
(5.5 ± 1.4) x10-3
0.0455 ± 0.0013
8±2
Enzyme solutions consisted of a 50 mM ACES buffer solution at pH 7.0 and 600 nM MCA. Substrate buffer solutions were matched with the above buffer with which an
aqueous stock solution of 2-aminophenol was diluted at various concentrations and H2O2
was added (200 μM.) 2-Aminophenol, H2O2, and M-CA concentrations were halved in
the stopped-flow mixer before measuring the reaction rate. [All reported values are
representative of the average of five replicates.]
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Figure 3.8

Oxidation of 2-aminophenol by Fe-CA activation of H2O2

Enzyme solutions consisted of a 50 mM ACES buffer solution at pH 7.0 and 600 nM MCA. Substrate buffer solutions were matched with the above buffer with which an
aqueous stock solution of 2-aminophenol was diluted at various concentrations and H2O2
was added (200 μM.) 2-Aminophenol, H2O2, and M-CA concentrations were halved in
the stopped-flow mixer before measuring the reaction rate. [All reported values are
representative of the average of five replicates. Error bars represent the standard
deviation of the five replicates.]
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Figure 3.9

Oxidation of 2-aminophenol by Cu2CA activation of H2O2

Enzyme solutions consisted of a 50 mM ACES buffer solution at pH 7.0 and 600 nM MCA. Substrate buffer solutions were matched with the above buffer with which an
aqueous stock solution of 2-aminophenol was diluted at various concentrations and H2O2
was added (200 μM.) 2-Aminophenol, H2O2, and M-CA concentrations were halved in
the stopped-flow mixer before measuring the reaction rate. [All reported values are
representative of the average of five replicates. Error bars represent the standard
deviation of the five replicates.]
The kinetic parameters collected for Fe-CA include an unusually large KM. These
values were sought for free iron in solution, but the free metal showed no activity. The
size of the KM suggests that the Fe-CA activity proceeds by a radical mechanism. The
reaction between iron and hydrogen peroxide leading to hydroxyl or peroxyl/superoxide
radicals is referred to as the Fenton reaction or, generally, Fenton chemistry, shown
below. The high kcat may be due to the ability of both Fe2+ and Fe3+ to produce radicals
capable of oxidizing the substrate.
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3.2.2
3.2.2.1

Fe2+ + H2 O2 → Fe3+ + HO∙ + OH-

Reaction 3.6

Fe3+ + H2 O2 → Fe2+ + HOO∙ + H+

Reaction 3.7

Disproportionation of hydrogen peroxide
Background
Catalase catalyzes the disproportionation of hydrogen peroxide. In action,

catalase outperforms all other enzymes by far (ε = 6.61 x 107 M-1 s-1).156 Therefore, this
reaction will be discussed here as a way to specifically model catalase’s activity.

Reaction 3.8
3.2.2.2

Methodology
Details of the water purification system and most of the chemicals used are listed

in section 3.1.1.2. A description of the purification of CA can be found in Chapter II. As
discussed in section 3.2.1.2, the concentration of hydrogen peroxide [50%, Aldrich,
CAS#: 7722-84-1] was determined spectroscopically to be 17.9 ± 0.3 M and stored at 20oC.155 The [H2O2] was determined at 240 nm with a Modernized Cary 14 UV/Vis/NIR
Spectrophotometer [Olis, Inc.] (ε240 nm = 43.6 M −1 cm−1 ).124
The rate of disproportionation of hydrogen peroxide was followed by decreased
absorbance at 240 nm by UV spectroscopy on a Modernized Cary 14 UV/Vis/NIR
Spectrophotometer [Olis, Inc.]. To minimize cuvette absorption near 200 nm, the
cuvettes were Hellma Analytics 104-QX semi-micro cells made of quartz SUPRASIL
300, which gives an 80% transmission in the range of 200 nm-3500 nm. The reaction
was initiated by adding M-CA (600 nM) to a cuvette containing a solution of 50 mM
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ACES at pH 7.0 and various concentrations of H2O2: 0.50, 0.75, 1.00, 1.25, 2.50, 5.00,
10.00, 20.00, 30.00, 35.00 mM.
3.2.2.3

Data and Discussion
As the normalized data in Figure 3.10 shows, none of the M-HCA-II variants

catalyzed the disproportionation of hydrogen peroxide. Even the drop in H2O2
concentration seemingly catalyzed by Ni-CA only represents a drop in 0.4 mM H2O2 over
about 2 minutes. Nevertheless, this chemistry was not catalyzed by any of the tested MHCA-II variants.

Figure 3.10

Normalized disproportionation of H2O2 by M-HCA-II

The different colors represent Zn-CA, red; Cu2-CA, green; Cu/Zn-CA, yellow; Fe-CA, dark blue; Mn-CA,
pink; Ni-CA, light blue; and Co-CA, gray. The reaction was initiated by adding M-CA (600 nM) to a
cuvette containing a solution of 50 mM ACES at pH 7.0 and various concentrations of H2O2. The inset has
a smaller y-axis range for the same data.
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3.2.3
3.2.3.1

Disproportionation of superoxide
Background
Four superoxide dismutase (SOD) variants have been characterized.157-161 These

variants are can have very different protein structures, but their general function is the
same and active site ligands are similar. The various SODs include Fe-SOD, Cu/ZnSOD, Mn-SOD, and Ni-SOD. SODs disproportionate superoxide into peroxide and
molecular oxygen.

Reaction 3.9
With respect to the metal ligand sites of the SODs, they are all histidine rich,
except Ni-SOD. The metal ligand sites of Fe-SOD and Mn-SOD are identical:
3His/1Asp. Within Cu/Zn-SOD, the copper site is a 3His coordination and zinc is
2His/1Asp. The 2Cys/1His site of the Ni-SOD is the exception. With these His rich
metal-binding, active sites, SODs provide an attractive set of enzymes for which to model
activity with M-HCA-IIs: Cu2-HCA-II, Cu/Zn-HCA-II, Mn-HCA-II, Fe-HCA-II, and
Ni-HCA-II. Co-HCA-II was also tested for SOD activity, as discussed later.
The assay for SOD activity involves four distinct, simultaneous reactions.125,162
The conversion of xanthine to uric acid by xanthine oxidase (XO) results in the reduction
of molecular oxygen to either peroxide (2 electron reduction) or, due to an uncoupling of
the reaction mechanism, superoxide (1 electron reduction.) The H2O2 generated by the
reaction is an unnecessary detriment to the enzyme, so adding catalase to the reaction
prevents the build up of H2O2. The generation of superoxide is monitored by the reaction
of a cytochrome c. As superoxide is produced, cytochrome c is reduced and it begins to
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absorb light at 550 nm. The activity of SOD is determined by the reduced rate of the
generation of reduced cytochrome c. For this assay, one unit of activity is defined as the
milligrams of protein required to half the rate of reduced cytochrome c generated from
0.025 absorbance units min-1.

Reaction 3.10
Reaction 3.11
3.2.3.2

Methodology
Initially, the O2.- flux was established by varying the concentration of xanthine

oxidase (XO) [CALBIOCHEM, Lot#:D00104791] in the presence of 50 μM xanthine
[99%, AlfaAesar, CAS#: 69-89-6, Lot#: 10161006], 10 μM cytochrome c
[CALBIOCHEM, Lot#:D00136376], and 300 nM catalase [Sigma, Lot#: 038K7005].
The concentration of xanthine oxidase was varied until the flux of superoxide resulted in
a change in absorbance of 0.025 ± 0.003 min-1 at 550 nm. The buffer used for this assay
was 20 mM phosphate buffer at pH 7.8 [Na2HPO4: >99%, Sigma, CAS#: 7558-79-4,
Lot#: 116H1016; and NaH2PO4: 99.0%, BDH, CAS#: 7778-77-0, Lot#: 87952]. Due to
the lower metal-binding constants for some M-HCA-II variants, EDTA was not used in
this assay as originally prescribed by McCord and Fridovich.125
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Once the O2.- flux was established, the activity of the M-HCA-II variants were
tested by varying the concentration of the M-HCA-II and determining the mass in mg
necessary to inhibit the flux by 50% (0.0125 min-1). One unit of activity is defined as the
number of mg of enzyme necessary to produce this inhibition. The data collected is listed
in Table 3.7.
Table 3.7

Superoxide dismutation catalyzed by native superoxide dismutase enzymes
and M-HCA-II variants

SOD Assay
Units of Activity/mg Enzyme
Enzymes
Cu/Zn-SOD
3390163
Mn-SOD
3400164
Fe-SOD
2470165
Ni-SOD
3080163
Zn-CA
13 ± 1
Fe-CA
26 ± 3
Cu2-CA
121 ± 12
Mn-CA
26 ± 3
Ni-CA
14 ± 5
Co-CA
13 ± 1
Reaction solution were buffered with a 20 mM phosphate solution at pH 7.8. All
solutions contained 50 μM xanthine, 10 μM cytochrome c, and 300 nM catalase.
Concentrations of M-CA varied to investigate the reactivity, and concentrations of
xanthine oxidase were sufficient to maintain the required superoxide flux. [All reported
values are representative of the average of a minimum of three replicates.]
3.2.3.3

Data and Discussion
The dismutation of superoxide is catalyzed by native SOD variants at rates (i.e.

kcat/KM = 2 x 109 M-1s-1) nearing the diffusion-limited rate constant (i.e. kd ≈ 109-1011 M-1
s-1).166,167 Although the values collected for M-HCA-II variants are much lower than
those of the SOD enzymes, it is unreasonable to expect rates from M-HCA-II near the
rate of diffusion. The values listed in Table 3.7 are not catalytic rates because a method
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to generate a saturating concentration of O2.- was not available to the Emerson group
during this study.
The ability of Mn-CA and Cu2-CA to catalyze this reaction better than the other
M-HCA-II variants may indicate that mutations in the HCA-II may improve the CA
models for Mn-SOD, Cu/Zn-SOD. Reconstitution of the apo-SOD variant of Cu/ZnSOD with two equivalents of Cu2+ has been shown already to recover near full SOD
activity.168 The Mn-CA is a better model for Mn-SOD than are the other model enzymes.
It is the inability for Fe-CA to catalyze this reaction that is surprising. The ability
of Fe-CA to catalyze the oxidation of 2-aminophenol in the presence of H2O2 shows that
the Fe-CA activates reactive oxygen species. In this assay Fe-CA is not able to react
catalytically with O2.- and the H2O2 produced in this assay is disproportionated by the
much faster catalase present in the reaction solution.
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CHAPTER IV
INHIBITION: WILD-TYPE AND METAL-SUBSTITUTED HUMAN CARBONIC
ANHYDRASE-II DERIVATIVES

The medicinal importance of the inhibition of CA has long been known,108,169 but
the relatively recently elucidated role of CA-IX in the proliferation of cancer cells
signifies the renewed importance of research into the inhibition of CA, generally, and
CA-IX, specifically. The first, most thoroughly studied, quintessential CA inhibitor is
sulfanilamide (Figure 4.1).18,47,170-172 However, in 2009 Maresca et al. presented
coumarin as the first member of a new class of suicide inhibitors for several isomers of
CA, including HCA-II.97 The Claudio Supuran group, from which this research
originated, has proposed that coumarin is hydrolyzed in the active site of CA to ocoumaric acid (2-hydroxycinnamic acid), which he describes as the source of inhibition.
(See Reaction 4.1.) Herein, I will present data that calls this new class of inhibitors into
question.

Figure 4.1

Sulfanilamide
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Reaction 4.1
4.2
4.2.1

Inhibition by sulfanilamide
Background
Inhibition of CA has been a focus even from its initial isolation and

characterization; the first full report of CA included the first reported inhibitors as well.29
Soon after, sulfonamides, especially sulfanilamide (Figure 4.1), were identified as highly
specific inhibitors for CA activity.170 Isomers of CA were not known at the time, and it
was later determined that sulfanilamide is a more powerful inhibitor for HCA-II by an
order of magnitude than it is for HCA-I. Other inhibitors exhibit this difference as well.
In fact, there are several small-anion inhibitors that limit the activity of HCA-I 100 times
greater than HCA-II.172
The crystal structure of HCA-II bound to sulfanilamide was solved at 5.5 Å
resolution in 1967.88 According to that structure, there are three regions of the
sulfanilamide structure that bind to CA. The aromatic region interacts with the
hydrophobic pocket near the active site, and the sulfonamide nitrogen and oxygen bind to
the zinc in its fourth (displacing the water) and fifth coordination sites, respectively.
Sulfanilamide-metal binding in the active site informs the observation within a later
report that M-BCA variants are not equally susceptible to inhibition by sulfanilamide:
Zn2+ ≈ Co2+ > Cu2+, Cd2+ > Mn2+, Ni2+.60 The Ki for this noncompetitive inhibition has
been reported previously with a great variation depending on the report.1,172,173
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Previously reported Ki values are listed in Table 4.1. Other than the trend in M-BCA
variants listed above, no Ki values for metal variants of any CA isomers have been
reported.
Table 4.2

Sulfanilamide inhibition of Zn-CA

Ki (μM)
pH
Temperature (oC)
Reference
172
2
(not reported)
0
*
173
2300
7.0-10.0
0.2
173
2500
7.0-10.0*
15
174
0.3
7.5
20
*
The pH was allowed to change over time in a modified Wilbur-Anderson method.175
4.2.2

Methodology
Inhibition of Zn-CA, Cu2CA, and Cu/Zn-CA was investigated with sulfanilamide,

coumarin, and o-coumaric acid for the hydrolysis of both CO2 and p-nitrophenyl acetate.
These hydrolysis assays were performed as described in sections 3.1.1.2 and 3.1.2.2. The
stock sulfanilamide [≥99%, Sigma-Aldrich, CAS#:63-74-1, Lot#:109K0086] solution
(10.95 mM) was prepared in water. The sulfanilamide concentration varied: 300 μM,
100 μM, 50 μM, 10 μM, 1 μM, 500 nM, and 100 nM. The sulfanilamide was incubated
with the M-HCA-II at 4oC overnight in the assay buffer solution - 50 nM M-HCA-II, 20
mM HEPES at pH 7.5, and 20 mM Na2SO4 (200 μM phenol red was included for the
CO2 hydrolysis.) The solution prepared for the other syringe included 20 mM HEPES at
pH 7.5, 20 mM Na2SO4, and 35 mM CO2 or 12 mM p-nitrophenyl acetate.
4.2.3

Data and discussion
With respect to Zn-CA, Figures 4.2 and 4.3 clearly show the ability of

sulfanilamide to inhibit the hydrolysis of CO2 and p-nitrophenyl acetate. The curve fits
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calculated by SigmaPlot 10.0 give IC50 values within the ranges previously reported.
Table 4.2 lists the Ki values determined from the fits for Figures 4.2 and 4.3.
Table 4.3

Sulfanilamide Ki values

K i(𝑝−NPA∗) (M)
K i(CO2) (M)
M-HCA-II
-6
Zn-CA
(8.9 ± 1.1) x10
(8.4 ± 1.0) x10-6
Cu2-CA
(11 ± 2) x10-6
-Cu/Zn-CA
(8.8 ± 1.4) x10-6
(8.4 ± 1.4) x10-6
Enzyme-inhibitor solutions consisted of a 20 mM HEPES/ 20mM Na2SO4/ 200 μM
phenol red buffer solution at pH 7.50 and 50 nM M-CA, incubated overnight with various
concentrations of sulfanilamide. Substrate buffer solutions were matched with the above
buffer (without phenol red) and either equilibrated with CO2 (35 mM) or prepared with pnitrophenyl acetate (12 mM). Substrate, incubator, and M-CA concentrations were
halved in the stopped-flow mixer before measuring the reaction rate. [All reported values
are representative of the average of five replicates.]
*
p-nitrophenyl acetate

77

Figure 4.2

Inhibition of M-CA CO2 hydrolysis

Inhibition of Zn-CA (red), Cu2CA (green), Cu/Zn-CA (yellow) CO2 hydrolysis by
sulfanilamide (A), coumarin (B), and o-coumaric acid (C). See section 4.1.2 for reaction
conditions. [All reported values are representative of the average of five replicates. Error
bars represent the standard deviation of the five replicates.]
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Figure 4.3

Inhibition of M-CA p-nitrophenol acetate hydrolysis

Inhibition of Zn-CA (red), Cu2CA (green), Cu/Zn-CA (yellow) p-nitrophenyl acetate
hydrolysis by sulfanilamide (A), coumarin (B), and o-coumaric acid (C). See section
4.1.2 for reaction conditions. [All reported values are representative of the average of
five replicates. Error bars represent the standard deviation of the five replicates.]
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With respect to Cu/Zn-CA and Cu2-CA, there have been no previous reports with
which to compare the data presented here. The inhibition of Cu/Zn-CA approximates the
inhibition of Zn-CA. Although within this study the inhibition of sulfanilamide was first
investigated as a way to control for the validity of the method used to investigate the
inhibition by coumarin and o-coumaric acid, the data collected inform the catalysis of
Cu2-CA. These inhibition data further lend credence to the idea that the hydrolytic
activity seen with Cu2-CA is from the low affinity CuB site, not some contamination of
the Cu2-CA with Zn2+. The fact that Cu2CA has both a significantly different activity and
inhibition by sulfanilamide from Zn-CA while Cu/Zn-CA lends credence to the idea that
the CuB site in Cu2-CA is responsible for the activity seen.
The reduced ability of sulfanilamide to inhibit Cu2-CA is further evidence
supporting our assertion that it is indeed Cu2-CA, not zinc contamination, which is
reactive in the CuB site. With respect to Cu2-CA, if zinc contamination were the cause of
observed CO2 hydrolysis, then it is that contaminant which is inhibited by sulfanilamide,
and the same contaminant would be present in the same concentrations during the
hydrolysis of p-nitrophenyl acetate, which would provide a catalyst susceptible to
sulfanilamide and yielding an observable inhibition. Instead, the relative rates of
hydrolysis observed are starkly different with Cu2-CA hydrolyzing CO2 at 67.5 ± 1.1
percent and p-nitrophenyl acetate at 0.364 ± 0.010 percent of the rate seen with Zn-CA.
The Ki values draw an even clearer distinction. Sulfanilamide inhibits Zn-CA
with a Ki values of 8.9 x10-6 ± 1.1x10-6 M (CO2 hydrolysis) and 8.4 x10-6 ± 1.0 x10-6 M
(p-nitrophenyl acetate.) For Cu2CA, these values become 1.1 x10-5 ± 0.2 x10-5 (higher
than for Zn-CA by a factor of 1.2) or are below detection limits, respectively. If the
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sulfanilamide were inhibiting a zinc contaminant, the concentration of sulfanilamide
necessary to inhibit that contaminant would be much lower (i.e. lower Ki) than that
needed to inhibit Zn-CA, but what is observed is that the Cu2CA requires 1.2 times as
much sulfanilamide. As for the Ki collected for the hydrolysis of p-nitrophenyl acetate,
the value is absurd, and it is only presented here to indicate that the inhibition data shows
no inhibition by sulfanilamide for the residual activity seen in this reaction. These data
clearly refute past reports that Cu2+ is an inhibitor for HCA-II.
4.3
4.3.1

Inhibition by coumarin and 2-hydroxycinnamic acid
Background
The metabolism of coumarin in the body has long been investigated.176-187

Coumarin derivatives have been shown to interact in multiple ways with blood plasma
enzymes, including the hydrolysis of coumarin (Structure 4.2) which produces ocoumaric acid (Structure 4.3). Even though, CA is a blood protein, the interaction of
coumarin derivatives with CA has rarely been reported. Fierke published a report in
which she used a coumarin-based fluorescent probe with HCA-II as a biosensor for
zinc.93 This does not include an investigation into the inhibition of CA by the probe,
although the ability to follow the binding of coumarin indicates that the coumarin base
remains intact in a solution of HCA-II. The only other reports which explicitly
investigate the interaction of any CA isomer with coumarin originate in the Claudio T.
Supuran group at the Università degli Studi di Firenze. The Supuran group has published
reports that coumarin behaves like a suicide inhibitor for a number of CA
isomers.20,23,97,98,122 It is asserted in these reports that CA hydrolyzes coumarin to form o-
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coumaric acid, which is believed to cause the inhibition. According to the Supuran group,
the Ki for this inhibition is 9.2 μM.122
The proposed mode of action for the inhibition is unusual in that it does not occur
through coordination with the metal center. There have not been reports of crystal
structures of HCA-II-coumarin nor HCA-II-o-coumaric-acid, but a crystal structure is
reported for HCA-II in complex with the hydrolyzed product of a derivative of coumarin
(i.e. derivative: 6-(1S-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one, D1;
hydrolyzed product: cis-2-hydroxy-4-(1S-3-methylbutyl)-3-methoxy-cinnamic acid,
HP1). In this structure HP1 (which is presumed to be the actual inhibitor) is associated
non-covalently with residues near the rim of the conical opening around the active site.
There are no data presented apart from the Ki to describe the proposed inhibition.
Herein, I detail the data taken in our lab, which contradict this inhibitory activity. We
have found that neither coumarin nor o-coumaric acid inhibit Zn-HCA-II, Cu2-HCA-II,
or Cu/Zn-HCA-II.
4.3.2

Methodology
Inhibition by coumarin [Eastman Kodak Company, CAS#: 91-64-5] and 2-

hydroxycinnamic acid [97%, Aldrich, CAS#: 614-60-8, Lot#: STBD3151V] was
followed by the same method described in section 4.1.2. Coumarin was not purchased
from Eastman recently, so the inhibitor was determined to be pure by measuring the
melting point (68.5-69.7oC.) The accepted melting point is 68-70oC.188
The aqueous solubility of coumarin and 2-hydroxycinnamic acid is low in water
at room temperature.188 Hot water was used to prepare the solutions of both substrates
(i.e. 12.98 mM and 10.70 mM, respectively.) Coumarin remained in solution after
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preparation with hot water, but o-coumaric acid crystallized as the solution cooled.
Adding a single drop of 10 mM NaOH to the 50 mL o-coumaric acid solution ionized the
o-coumaric acid, making it soluble. The salt solution was yellow, whereas the ocoumaric acid solution was uncolored.
4.3.3

Data and discussion
All data collected for the inhibition of CA by coumarin show that coumarin does

not inhibit CA. Contrary to reports by Supuran et al. and in support of observations made
in the labs of Dr. Seth Cohen100 and Dr. Daumantas Matulis,101 our data show not the
slightest inhibition from coumarin. The data associated with HCA-II inhibition by
coumarin show that no inhibition is observed with coumarin.
According to Dr. Supuran et al., CA hydrolyzes coumarin opening the lactone
ring forming o-coumaric acid, which binds CA near the active site, which inhibits the
activity of CA. Therefore, we tested for the inhibition due to o-coumaric acid, but no
inhibition was observed. Again, the data associated with HCA-II inhibition by ocoumaric acid show that no inhibition is observed with o-coumaric acid.
4.4

Conclusion
In short, this work demonstrates that our very long-standing search to understand

the properties of carbonic anhydrase are not yet nearing an end. The incredible
importance and ubiquity CA should now be obvious to the reader, and in light of
unresolved old and new misunderstandings about carbonic anhydrase the need to
continue and intensify the study of this enzyme should be clear. The work described here
accounts for a limited scope in a much larger effort to clarify the nature of carbonic
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anhydrase and to elucidate new functions for it, like water-stable, end-on Co- and Cusuperoxo complexes and trace metal detection. As the reader nears the back cover of this
work, he/she must keep in mind that the greater book on carbonic anhydrase research is
far from closed.
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